Controlled surface-associated delivery of genes and oligonucleotides by Segura, Tatiana et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Biological Systems Engineering: Papers and 
Publications Biological Systems Engineering 
4-2006 




Lonnie D. Shea 
Northwestern University, 
Angela K. Pannier 





See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/biosysengfacpub 
 Part of the Biological Engineering Commons 
Segura, Tatiana; Shea, Lonnie D.; Pannier, Angela K.; Bengali, Zain; Jang, Jae-Hyung; Chung, Peter; and 
Anderson, Brian C., "Controlled surface-associated delivery of genes and oligonucleotides" (2006). 
Biological Systems Engineering: Papers and Publications. 145. 
https://digitalcommons.unl.edu/biosysengfacpub/145 
This Article is brought to you for free and open access by the Biological Systems Engineering at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Biological Systems 
Engineering: Papers and Publications by an authorized administrator of DigitalCommons@University of Nebraska - 
Lincoln. 
Authors 
Tatiana Segura, Lonnie D. Shea, Angela K. Pannier, Zain Bengali, Jae-Hyung Jang, Peter Chung, and Brian 
C. Anderson 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
biosysengfacpub/145 
(12) United States Patent 
Segura et al. 
(10) Patent No.: US 7,029,697 B2 
(45) Date of Patent: *Apr. 18,2006 
(54) CONTROLLED SURFACE-ASSOCIATED 
DELIVERY OF GENES AND 
OLIGONUCLEOTIDES 
(75) Inventors: Tatiana Segura, Evanston, IL (US); 
Lonnie D. Shea, Evanston, IL (US); 
Angela Kave Pannier, Glenview, IL 
(56) References Cited 
U.S. PATENT DOCUMENTS 
6,312,727 B1 1112001 Schacht et al. 
6,544,790 B1 * 412003 Sabatini ...................... 4351455 
200210197720 A1 1212002 Uhler 
200310077824 A1 412003 Uhler 
(u:); zainU~engali,  Naperville, IL OTHER PUBLICATIONS 
(US); Jae-Hyung Jang, Skokie, IL 
(US); Peter Chung, Montgomery, AL Zheng et al., Biotechnol. Prog., vol. 16,2000, pp. 254-257." 
(US); Brian C. Anderson, Libertyville, Adami, et al., J. Pharm. scl., 87:678-683 (1998). 
IL (Us) Bonadio, et al., Nat. Med., 5:753-759 (1999). 
Bielinska, et al., Biomaterials, 21:877-887 (2000). 
Assignee: Northwestern University, Evanston, IL 
(US) 
Notice: Subject to any disclaimer, the term of this 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 17 days. 
This patent is subject to a terminal dis- 
claimer. 
Appl. No.: 101893,572 
Filed: Jul. 15. 2004 
Prior Publication Data 
US 200510090008 A1 Apr. 28, 2005 
Related U.S. Application Data 
Continuation-in-part of application No. 101076,060, 
filed on Feb. 14, 2002, now Pat. No. 6,890,556. 
Provisional application No. 601268,626, filed on Feb. 
14, 2001. 
Int. C1. 
A61K 9/12 7 (2006.01) 
U.S. C1. ................... 4241450; 4351458; 4351320.1; 
536123.1 
Field of Classification Search ................ 4241450; 
4351458, 320.1; 536123.1 
See application file for complete search history. 
Bielinska, et al., Biochem. Biophys. Acta, 1353: 180-1 90 
(1997). 
Duguid, et al., Biophys J., 74:2802-2814 (1998). 
Fischer, et al., Pharm. Res., 16:1273-1279 (1999). 
Gao, et al., Biochemistry, 35:1027-1036 (1996). 
Luo, et al., Nat. Biotechnol. 18:893-895 (2000). 
Shea, et al., Nat. Biotechnol., 17:551-554 (1999). 
Vitiello, et al., Gene Ther., 3:396-404 (1996). 
Zheng, et al., Biotechnol. Prog., 16:254-257 (2000). 
* cited by examiner 
Primary Examiner-James Ketter 
(74) Attorney, Agent, or Firm-Klauber & Jackson 
(57) ABSTRACT 
A system and methods for controlled gene delivery com- 
prising condensed nucleic acids complexed with polylink- 
ers, wherein the complexes are covalently andor non- 
covalently bound to the surface of a substrate capable of 
supporting cell adhesion. The gene delivery system achieves 
temporal and spatial control of nucleic acid delivery to a 
target cell or cells through control of complex density on the 
surface of the support substrate, and reversibility of the 
attachment of the polylinker to the support substrate. The 
system and method of the invention can be used to create 
spatial patterns of gene expression, and in tissue engineer- 
ing, high throughput screening, and gene therapy applica- 
tions. 
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CONTROLLED SURFACE-ASSOCIATED PEI covalently attached to a biodegradable polymer sur- 
DELIVERY OF GENES AND face and to surface-immobilized collagen has been used as 
OLIGONUCLEOTIDES a gene delivery system. For example, Zheng et al. (2000) 
Biotechnol. Prog. 16:254-257, created a polymer surface 
CROSS-REFERENCE TO RELATED 5 with attached PLL and PEI, to which DNA was non- 
APPLICATIONS specifically adsorbed for delivery into a cell. 
Recently, polymeric systems originally developed to 
The present application is a continuation-in-part of U.S. deliver biologically active proteins have been adapted to 
application Ser, No, 101076,060, filed Feb, 14, 2002, now deliver non-viral DNA. Polymeric scaffolds have been fab- 
U.S. Pat. No. 6,890,556, which claims priority to provisional 10 ricated from a variety of materials, both natural (e.g., 
application Ser. No. 601268,626, filed Feb. 14, 2001, the collagen) and synthetic (e.g., pol~(lactide-co-gl~colide)) 
disclosures of which are hereby incorporated by reference in which function as a support for cell adhesion and migration. 
their entireties, Applicants claim the benefits of this appli- These scaffolds act to increase the local concentration of 
cation under 35 U.S.C. §I19 (e) and §35 U.S.C. 120. DNA within the cellular microenvironment either by pro- 
15 viding a sustained release of DNA (Shea et al. (1999) Nat. 
GOVERNMENT RIGHTS CLAUSE Biotechnol. 17:551-554) or by maintaining the DNAlocally 
(Bonadio et al. (1999) Nat. Med. 5:753-759). Bielinska et al. 
ne research leading to the present invention was sup- (2000) Biomaterials 21:877-887 describe the use of a solid 
ported by National Science Foundation Grant Number R01- membrane as a device for DNA mediated 
GM066839-0141 and National Institutes of Health Grant 20 dendrimers skin systems 
Number BES-0092701, Accordingly, the Government has have also been developed that increase cell-surface concen- 
certain rights in the invention. trations of DNAby adsorbing DNAcomplexes to the surface 
(Luo et al. (2000) Nat. Biotechnol. 18:893-895). U.S. Pat. 
FIELD OF THE INVENTION NO. 6,312,727 describes a nucleic acid delivery vehicle in 
25 which comnlexes formed from nucleic acids condensed with 
cationic polymer material are reacted with hydrophilic poly- 
The present invention relates to methods for the con- mer material to form a hydrophilic coating or shield around 
trolled delivery of a nucleic acid into a cell. More specifi- the complex, 
cally, the invention relates to methods of targeting and - - 
controlling the delivery of a nucleic acid to a cell or cell 30 SUMMARY OF THE INVENTION 
population with a system comprising DNA complexed to a 
polylinker which is attached to a support substrate. The present invention provides for novel systems for the 
controlled delivery of a nucleic acid to a target cell or cells 
BACKGROUND OF THE INVENTION that combines nucleic acid condensation with polymeric 
35 delivery by tethering or immobilizing nucleic acid com- 
Developing systems capable of controlled and efficient plexes to a surface that supports cell adhesion. The gene 
gene transfer is a fundamental goal of biotechnology, with delivery system of the invention allows both temporal and 
applications ranging from basic science to clinical medicine. spatial control of gene delivery due to efficient internaliza- 
Increasing or decreasing the expression level of a gene tion of the immobilized complex, elevated DNA concentra- 
within a cell has the power to reveal or confirm the roles of 40 tions in the microenvironment of cells adhered to the support 
specific components of signaling pathways and can lead to substrate, and through alterations in the number of tether to 
a mechanistic understanding of cell behavior, disease patho- the complexes and reversibility of complex immobilization. 
genesis, and drug action. The successful application of gene The present invention also provides gene delivev by 
transfer for basic science and clinical medicine requires the plasmids that are complexed with cationic polymers (poly- 
ability to manipulate the expression of target genes in the 45 plexes) or lipid (lipoplexes) and subsequently immobilized 
desired cell population. A variety of approaches are being to cell culture or biomaterial substrates by adsorption. Poly- 
taken to develop techniques to overcome barriers to gene plexes and lipoplexes were adsorbed to either unmodified 
transfer, which includes processes such as cellular internal- (PS) or serum-adsorbed (FBS-PS) polystyrene, The quantity 
ization, endosomal escape, and nuclear trafficking. of DNA immobilized increases with time of exposure, and 
Cationic polymers provide a versatile approach for gene 50 the deposition rate and final amount deposited depends upon 
transfer as the polymers can be designed or modified to the properties of the substrate and complex. For maximal 
overcome some of the current problems encountered with transfection, this approach requires that the affinity of the 
gene transfer. Complexation with cationic polymers func- DNA complex for the substrate must be sufficient to support 
tions to condense DNA, to produce a complex with a immobilization, yet not excessive to limit cellular internal- 
less-negative surface charge, to enhance cellular internal- 55 ization. 
ization of DNA, and to protect the DNA from degradation. The studies reported on herein have focused on manipu- 
Although many types of cationic polymers have been lating the properties of the complex and substrate to modu- 
explored (see, for example, van de Wetering et al. (1999) late this binding affinity. Polyplexes and lipoplexes were 
Bioconjug. Chem. 10:589-597), polymers based on poly(L- examined based on their differences in chemical composi- 
lysine) (PLL)(see, for example, Choi et al. (1999) Biocon- 60 tion, size, and zeta potential, which may affect their inter- 
jug. Chem. 10:62-65), poly(ethy1enimine) (PEI) (see, for action with the substrate. Additionally, serum adsorption 
example, Blessing et al. (2001) Bioconjug. Chem. was used as a simple approach to modulate the interaction of 
12:529-537), poly(amidoamine) (PAMAM) (see, for these complexes with the culture substrate. Substrate bind- 
example, Qin et al. (1998) Hum. Gene Ther. 9:553-560), ing andcellulartransfection (i.e., transfectedcells, transgene 
and poly(2-dimethylamino)ethylmethacrylate 65 expression) were measured for polyplexes and lipoplexes 
(p(DMAEMA)) (Arigita et al. (1999) Pharm. Res. formed with varying amounts of cationic polymer or lipid, 
16: 1534-1 541) are among those utilized. respectively. The mechanism of gene transfer was examined 
US 7,029,697 B2 
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through the distribution and stability of complexes on the bonded to the support substrate. In a specific embodiment, a 
substrate. Furthermore, the invention demonstrates that sub- covalent bond between a polylinker and the support sub- 
strate-mediated delivery can transfect primary human-de- strate is broken after a cell is plated on the support surface. 
rived cells, and that this approach can be extended to widely In specific embodiments, the nucleic acid is DNA, RNA, 
used biomaterials. 5 or an oligonucleotide. In a more specific embodiment, the 
For polyplexes, serum modification maximally enhanced oligonucleotide is an antisense oligonucleotide or catalytic 
reporter gene expression 1500-fold relative to unmodified RNA capable of interfering with the expression of a gene. In 
substrates, and yields equivalent or greater expression com- another more specific embodiment, the DNAor RNAdirects 
pared to bolus delivery. For lipoplexes, serum modification the intracellular expression of a gene. 
significantly increased the number of transfected cells rela- l o  In more specific embodiments, the polylinker is a cationic 
tive to unmodified substrates, yet provided similar levels of polymer, cationic lipid, cationic protein, or cationic peptide. 
expression. Immobilized complexes transfect primary cells In a specific embodiment, the polylinker is a cationic poly- 
with lower cytotoxicity relative to bolus delivery. This mer or cationic peptide. 
substrate-mediated delivery approach was successfully The support substrate of the invention is any substrate 
applied to a widely used biomaterial, poly(1actide-co-gly- 1s capable of supporting cell adhesion. In more specific 
colide). embodiments, the support substrate is glass, collagen, pep- 
The invention also provides a substrate mediated strategy tide polymers, polysaccharide polymers, carbohydrate, 
for delivering DNA complexes from hyaluronic acid (HA)- polymers, polystyrene, lipid, metal, plastic, alumina gels, 
collagen hydrogels. Hydrogels were formed by crosslinking nitrocellulose, nylon membranes, cotton, or glass wool. In 
HAwith poly(ethy1ene glycol) diglycidyl ether, and a topog- 20 another embodiment, the support substrate is HA-collagen 
raphy was introduced using pattern transfer. DNMPEI com- hydrogel. The support substrate either contains or can be 
plexes of varied sizes were immobilized to the hydrogel chemically modified to contain a functional group that 
substrate using biotidneutravidin binding and non-specific allows the support substrate to covalently bind to a bifunc- 
adsorption. tional crosslinker or polylinker modified to have a functional 
Accordingly, in a first aspect, the invention features a 25 group. 
controlled nucleic acid delivery system comprising nucleic In the controlled nucleic acid delivery system of the 
acid-polylinker complexes tethered or immobilized to a invention, nucleic acid delivery is controlled through (i) 
support substrate, wherein the nucleic acid-polylinker com- complex density at the surface of the support substrate, (ii) 
plex is capable of being delivered or internalized by a cell complex location on the surface of the support substrate, and 
adhering to the support substrate. 30 (iii) the number of bonds linking the polylinkers in the 
The nucleic acid-polylinker complexes are immobilized complex to the support substrate. In one embodiment, the 
to the surface of a support substrate by a functional group bonds between the polylinkers and the support substrate are 
attached to the polylinker. A polylinker modified by a reversible. In a specific embodiment, complex density on the 
functional group may attach to the support substrate directly surface of the support substrate ranges from 0.01 to 10.0 pg 
or may attach through a modifying functional group present 35 DNA/cm2; and in a more specific embodiment, from 0.05 to 
on the support substrate. The polylinker may be modified 5.0 pg DNA/c~' .  
with a functional group before or after formation of the The relative strength of the attachment between the 
complex, but the complex must be formed prior to attach- immobilized complex and the support substrate, and the 
ment to the solid support. The polylinker may be modified reversibility of complex immobilization at the surface of the 
with a functional group before or after formation of the 40 support substrate are factors that determine the release rate 
complex, but the complex must be formed prior to attach- of a complex from the support substrate, and the availability 
ment to the solid support. of the released complex for internalization, e.g., delivery, to 
The complexes may be covalently or non-covalently a cell or cell population. 
immobilized. In one embodiment, the complexes are In a second aspect, the invention features a method of 
covalently attached to the support substrate. In this embodi- 45 controlled nucleic acid delivery, comprising (a) contacting a 
ment, the complexes may be formed by condensation of the nucleic acid with a polylinker, wherein the nucleic acid 
nucleic acid with a non-modified polylinker. The complex is complexes with the polylinker to form a nucleic acid- 
then reacted with a functional group on the support substrate polylinker complex, and (b) immobilizing the nucleic acid- 
to generate a covalent bond between the polylinker and the polylinker complex of step (a) to a support substrate able to 
support substrate. In another embodiment of the covalent 50 support cell adhesion, wherein the immobilization is through 
attachment of the complexes to the support substrate, the the polylinker, and wherein delivery of the nucleic acid to a 
nucleic acid is condensed with a modified polylinker. The cell is controlled by (i) density and location of the complex 
resulting complex is then reacted with a functional group on on the surface of the support substrate, and (ii) the number 
the solid support to generate a covalent bond between the of bonds attaching the polylinkers in the complex to the 
polylinker and the support substrate. In another embodi- 55 support substrate. 
ment, the complexes are non-covalently immobilized to the In specific embodiments, the complexes may be 
support substrate. In this embodiment, the complexes may covalently or non-covalently immobilized through the 
be formed by condensation of the nucleic acid with a polylinker to the support substrate. In one embodiment, the 
non-modified polylinker. The complex is then modified with complexes are covalently attached to the support substrate. 
a functional group that will specifically interact with a 60 In another embodiment, the complexes are non-covalently 
functional group on the solid support to generate a non- immobilized to the support substrate. In either embodiment, 
covalent bond. In another embodiment of the non-covalent the complexes may be formed by condensation of the 
attachment of the complexes to the support substrate, the nucleic acid with a modified polylinker, by condensation of 
nucleic acid is condensed with a modified polylinker. The the nucleic acid with a non-modified polylinker, or by 
complex is then reacted with a functional group on the solid 65 condensation of the nucleic acid with a mixture of modified 
support to generate a non-covalent bond. In one embodi- polylinker and non-modified polylinker. The number of 
ment, more than 0.2% of the immobilized complexes are bonds linking the polylinker to the support substrate can be 
US 7,029,697 B2 
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manipulated by i) varying the extent of modification of the face of a support substrate, wherein the surface of the 
polylinker, or ii) varying the ratio of modified to non- support substrate is modified with a second functional group 
modified polylinker during complex formation. capable of interacting with the first functional group, and 
In one embodiment, the support substrate is modified with wherein the modified polylinker present in the complex is 
a functional group capable of interacting with the non- 5 specifically bound to the support surface, and wherein the 
modified polylinker in the complex. In another embodiment, specifically bound complexes are released at desired times 
the polylinkers are modified with a first functional group and internalized by a cell adhering to the surface of the 
prior to step (a) and the support substrate is modified with a support substrate. 
second functional group capable of interacting with the first In a sixth aspect, the invention features a method of 
functional group. In one embodiment, the nucleic acid is l o  temporally and spatially controlling the delivery of a nucleic 
contacted with both modified and unmodified polylinkers, acid to a cell population comprising: (a) modifying a 
forming nucleic acid-polylinker complexes which bind to polylinker with a first functional group; (b) contacting a 
the support substrate with varying binding strengths, and nucleic acid with modified polylinker; wherein the nucleic 
thus are released over a period of time as a result of the acid complexes with the polylinker to form a condensed 
different bond strengths. In another embodiment, the bond 1s nucleic acid; and (c) immobilizing the nucleic acid- 
between the polylinker and the support substrate is revers- polylinker complex to a surface of a support substrate, 
ible. In a further embodiment, the support substrate may be wherein the surface of the support substrate is modified with 
modified with a second functional group able to interact with a second functional group capable of interacting with the 
the first functional group modifying a polylinker. In a first functional group, and wherein complexes formed with 
specific embodiment, polylinker is poly-L-lysine (PLL), the 20 modified polylinker are specifically bound to the support 
first functional group is biotin, and the second functional surface and located at specific regions of the substrate in a 
group is avidin, strepavidin, or an avidin derivative. defined pattern, and wherein the specifically bound com- 
In a third aspect, the invention features a method of plexes are released at desired times and internalized by a cell 
making a controlled nucleic acid delivery system, compris- adhering to the surface of the support substrate. 
ing (a) contacting a nucleic acid with polylinkers; wherein 25 In a seventh aspect, the invention provides methods for 
the nucleic acid complexes with the polylinkers to form a increasing transgene expression. In one embodiment, the 
condensed nucleic acid; and (b) immobilizing the polylinker method comprises making a controlled nucleic acid delivery 
present in the complex to a support substrate, wherein system, comprising forming nucleic acid polylinker com- 
delivery of the nucleic acid to a cell is controlled by (i) plexes, wherein the complexes are covalently or non-co- 
density and location of the complex on the surface of the 30 valently immobilized to the surface of a support substrate, 
support substrate, and (ii) reversibility of the attachment of and wherein the method comprises: 
the polylinker to the support substrate the number of bonds a) contacting a nucleic acid with a polylinker to form a 
linking the polylinker in the complex to the support substrate nucleic acid-polylinker complex; 
wherein a desired release rate is achieved. In one embodi- b) immobilizing the nucleic acid-polylinker complex to a 
ment, the polylinkers are modified with a first functional 35 support substrate; and wherein the cells are added to the 
group prior to step (a) and the support substrate is modified support substrate after immobilization of the nucleic 
with a second functional group capable of interacting with acid-polylinker complex to the support substrate. 
the first functional group. In a further embodiment, the In another embodiment, the method further comprises 
nucleic acid is contacted with both modified and unmodified modification of the support substrate with serum prior to 
polylinkers. 40 addition of the nucleic acid-polylinker complex, and 
In a fourth aspect, the invention features a method of wherein said modification allows for an increase in trans- 
spatially controlling the delivery of a nucleic acid to a cell gene expression. 
comprising: (a) modifying a polylinker with a first func- In yet another embodiment, the extent of transgene 
tional group; (b) contacting a nucleic acid with modified expression is dependent upon substrate modification and 
polylinker; wherein the nucleic acid complexes with the 45 complex formation. In a particular embodiment, the nucleic 
polylinker to form a condensed nucleic acid; and (c) immo- acid polylinker complexes are polyplexes or lipoplexes. In a 
bilizing the nucleic acid-polylinker complex to a surface of particular embodiment, the increase in transgene expression 
a support substrate, wherein the surface of the support occurs when the polyplexes are immobilized to the support 
substrate is modified with a second functional group capable substrate at low densities or low doses, such as, but not 
of interacting with the first functional group, and wherein 50 limited to the doses used herein. The optimal doses and 
complexes formed with modified polylinker are specifically densities of the polyplexes andlor lipoplexes may depend on 
bound to the support surface, and wherein the specific the support substrate used, as well as the cell type for which 
binding of the complexes to the surface of the support gene delivery is desired. The methods for determining such 
substrate is located at specific regions of the substrate in a would be known to one skilled in the art. In yet another 
defined pattern. 55 particular embodiment, the increase in transgene expression 
In one embodiment, the nucleic acid is contacted with is optimized at a particular NIP ratio, which also may be 
both modified and unmodified polylinker in step (a) and the optimized depending on the substrate used and the cell type 
unmodified polylinker in the complex is not bound to the for which gene delivery is desired. 
support surface in step (c). In a specific embodiment, the In yet another particular embodiment, the support sub- 
substrate is a microtiter plate comprising multiple wells. 60 strate is biodegradable or non-biodegradable. In a more 
In a fifth aspect, the invention features a method of particular embodiment, the support substrate is polystyrene 
temporally controlling the delivery of a nucleic acid to a cell (PS), gold, or poly(1actide-co-glycolide) (PLG). In yet 
population comprising: (a) modifying a polylinker with a another particular embodiment, the support substrate is a 
first functional group; (b) contacting a nucleic acid with hydrogel. In a more particular embodiment, the hydrogel is 
modified polylinker; wherein the nucleic acid complexes 65 hyaluronic acid (HA)-collagen hydrogel. 
with the polylinker to form a condensed nucleic acid; and (c) In yet another embodiment, the support substrate may be 
immobilizing the nucleic acid-polylinker complex to a sur- treated with (modified) serum, such as but not limited to, 
fetal bovine serum. In a particular embodiment, the delivery 
of the nucleic acid-polylinker complexes to cells occurs 
from a polystyrene surface treated with serum, and such 
delivery results in a similar or a greater percentage of 
transfected cells relative to bolus delivery. In yet another 
particular embodiment, such delivery further comprises 
release of the nucleic acid from the nucleic acid-polylinker 
complexes, and the release is maximized when the support 
substrate is pretreated with serum. In yet another 
embodiment, the release of nucleic acid from the nucleic 
acid-polylinker complexes is further enhanced when the 
support substrate containing the complexes is incubated in 
conditioned medium. In yet another particular embodiment, 
the delivery of the nucleic acid-polylinker complexes to 
cells from a serum-modified support substrate results in 
higher cellular association of the nucleic acid-polylinker 
complexes with the support substrate. 
In an eighth aspect, the invention provides a method for 
increasing transgene expression, comprising the steps of 
a) making a controlled nucleic acid delivery system by 
contacting a nucleic acid with a polylinker to form a 
nucleic acid-polylinker complex; 
b) immobilizing the nucleic acid-polylinker complex to a 
support substrate; wherein said immobilizing is accom- 
plished by covalent or non-covalent means, and 
c) adding the cells into which transgene expression is 
desired to the support substrate after immobilization of 
the nucleic acid-polylinker complex to the support 
substrate. 
In one particular embodiment, the support substrate com- 
prises a biodegradable or non-biodegradable material. In a 
more particular embodiment, the biodegradable material is 
poly(1actide-co-glycolide) or a hydrogel and the non-biode- 
gradable material is polystyrene. In a more particular 
embodiment, the hydrogel is hyaluronic acid (HA)-collagen 
hydrogel. 
In yet another particular embodiment, the nucleic acid- 
polylinker complexes are formed prior to attachment to the 
solid support substrate. 
In another particular embodiment, the nucleic acid is 
DNA, RNA or an oligonucleotide. In a more particular 
embodiment, the oligonucleotide is an antisense oligonucle- 
otide or a catalytic RNA capable of interfering with the 
5 expression of a gene. 
In yet another particular embodiment, the polylinker is a 
cationic polymer, cationic lipid, cationic protein, or cationic 
peptide. . . 
Other objects and advantages will become apparent from 
10 a review of the ensuing detailed description taken in con- 
junction with the following illustrative drawings. 
BRIEF DESCRIPTION OF THE FIGURES 
15 FIG. 1 is a schematic depiction of DNA condensation 
(ionically localized) with polymeric delivery to tether DNA 
complexes to the surface of a hydrogel. 
FIG. 2 is a schematic depiction of the coupling of DNA 
complexes to the surface with a bifunctional cross-linker. 
20 FIG. 3 shows the quantity of surface associated DNA 
obtained following trypsinization of the slide. 
FIG. 4 shows the surface density of tethered DNMPoly- 
Lysine-Cys complexes. 
FIG. 5 depicts a method of surface modification and DNA 
25 tethering. 
FIG. 6 shows the chemical structures of bifunctional 
cross-linkers exemplifying some of the types of compound 
that can be employed by the present invention. These 
cross-linkers are bifunctional, e.g., having two reactive 
30 centers. As shown, these molecules have their reactive 
centers at opposite ends and can be used to bind two 
molecules together. 
FIG. 7 shows the results of HPLC analysis of the forma- 
tion of biotinylated K,,, starting material l and the reaction 
35 mixture 2. The shift in molecular weight between 1 and 2 
and absence of the low molecular weight peak in 2 con- 
firmed that the reaction went to completion. 
FIG. 8 shows the results of mass spectrometric analysis of 
the purified reaction mixture of the formation of biotinylated 
In yet another particular embodiment, the method pro- 40 K19. 
motes transfection of primary cells. In a particular embodi- FIG. 9 shows the density of surface-associated DNA for 
ment, the primary cells are fibroblast cells, although any complexes formed by mixing K,,,-B DNA with either K,, 
primary cell or cell line for which gene delivery is desired or K,,, at a charge ratio of 5.5. The moles of biotin per mole 
may be envisioned by the present invention. These may DNA (i.e., average number of biotin groups per complex), 
include neuronal cells, skin cells, stem cells, tumor cells and 45 which varied from 28 to 1705 for K,,,-B and 217 to 4342 
the like. for K,,-B, are listed beneath each bar. The symbol * 
In yet another particular embodiment, the nucleic acid indicates statistical significance (pe0.05) in the surface 
polylinker complexes are immobilized to the support sub- densities relative to complexes without biotin. 
strate using biotin and avidin or an avidin derivative, such as FIG. 10 shows the density of surface-associated DNA for 
streptavidin or neutravidin. In yet another particular embodi- so complexes formed by mixing K,,-B DNA with K,,,-B with 
ment, the nucleic acid-polylinker complexes are immobi- either K,, or K,,, at a charge ratio of 5.5 as described in 
lized to the support substrate by non-specific adsorption. FIG. 11. 
In yet another particular embodiment, the method further FIG. 11 shows the expression levels achieved by surface 
comprises controlling the size of the nucleic acid polylinker mediated transfection after 48 hours of incubation for 
complex by regulating the salt content during complex 55 HEK293T cells determined using an assay for fl-galactosi- 
formation. In a more particular embodiment, the forming of dase activity. The symbol * indicates statistical significance 
large diameter complexes in the presence of salt results in in transfection levels (pe0.05) relative to both bulk delivery 
increased transgene expression, and the forming of small conditions. 
diameter complexes in the absence of salt results in a greater FIG. 12 shows the expression levels achieved by surface 
percentage of cells being transfected. In a more particular 60 mediated transfection after 48 hours of incubation for NIHI 
embodiment, the salt is sodium chloride. 3T3 cells as described in FIG. 11. 
In yet another particular embodiment, the method further FIG. 13 shows expression levels achieved by surface 
comprises release of the nucleic acid from the substrate, mediated transfection after 96 hours of incubation for 
wherein the release is optimized by using conditioned HEK293T cells. 
medium. In a more particular embodiment, the method 65 FIG. 14 shows expression levels achieved by surface 
further comprises biotinylation of the complex to enhance mediated transfection after 96 hours of incubation for NIHI 
release of the complex from the substrate. 3T3. 
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FIG. 15 shows the diameter and zeta-potential of DNA seeding. Plasmid was labeled with tetramethyl-rhodamine 
complexes. (A) z-average diameter and (B) zeta potential of and cells were stained with fluorescein diacetate. 
PEI polyplexes with increasing polymerlDNA ratio (NIP). FIG. 23 shows transfection of primary human dermal 
(C) z-average diameter and (D) zeta potential of Lipo- fibroblasts. (A) GFP expression from bolus delivery of 0.5 
fectamine 2000 lipoplexes with increasing volumes of lipid 5 pg lipoplexes. (B) GFP expression from FBS-PS substrate- 
used to complex 1 pg of DNA. Data is presented as average mediated delivery of 1 pg lipoplexes incubated on substrate. 
+ standard deviation of the mean. * indicates pe0.05 relative Luciferase activity from substrate and bolus delivery of (C) 
to remaining data (A). ** indicates pe0.05 relative to NIP polyplexes and (D) lipoplexes. Data is presented as average 
equal to 5 (B). *** indicates ~ ~ 0 . 0 5  relative to 0.5 pL of +standard deviation of the mean. * indicates pe0.05 relative 
lipid. For this and all other figures, p values were obtained l o  to other delivery methods for that condition. 
using the Student's t test with single comparisons. FIG. 24 shows substrate-mediated transfection from 
FIG. 16 Shows the X-ray photoelectron spectrum of serum coated PLG. Polyplexes (5 pg) containing plasmid 
polystyrene and a serum modified polystyrene surfaces. The encoding for 0-galactosidase were incubated for 24 hours. 
peak denoted by the arrow indicates the presence of nitrogen Transfected cells appear blue, as indicated with the arrow. 
on the substrate. l5 FIG. 25 shows (A) z-average diameter of DNMPEI 
FIG. 17 shows DNA deposition and stability. (A) Poly- complexes at NIP ratios of 2.5, 5, 10 and 20 for complexes 
plexes (circles) and lipoplexes (triangles) were deposited formed in 150 mm NaCl or water. (B) Zeta potential of 
onto polystyrene (0, A) and serum coated polystyrene (0, DNMPEI complexes at NIP ratios of 2.5, 5, 10 and 20 for 
A) for 24 hours. Substrates were incubated with 2 pg of complexes formed in 150 mm NaCl. Plotted data is an 
DNA. (B) Immobilized polyplexes and lipoplexes were 20 average of triplicate conditions. 
exposed to phosphate buffered saline (PBS, pH=7.4) at 37' FIG. 26 shows DNMPEI complex aggregation. Com- 
C. Data is presented as average +standard deviation of the plexes were formed in water at different NIP ratios and 
mean. * indicates pe0.05 relative to FBS-PS deposition of complex size was monitored following addition of salt to the 
polyplexes after 24 hours. ** indicates ~ ~ 0 . 0 5  relative to complexes, Plotted data is an average of triplicate condi- 
lipoplexes released from PS at 8 days. 25 tions. 
FIG. 18 shows DNA adsorption to surface. Polyplexes FIG. 27 shows surface densities of DNMPEI complexes 
and lipoplexes were incubated on (A) PS and (B) FBS-PS immobilized to HA collagen-NA hydrogels for complexes 
surfaces for 2 hours. Black bars indicated 2 pg and gray bars formed in 150 mm NaCl or water (A). Plotted data is an 
indicated 0.5 pg of DNA incubated on the surface. Data is average of triplicate conditions. Fluorescence photomicro- 
presented as average +standard deviation of the mean. High 30 graphs of immobilized biotinylated DNMPEI complexes 
doses have pe0.05 relative to corresponding low doses at the (NIP=5) to HA-collagen-NA hydrogels. Biotinylated com- 
same NIP (A). * indicates pe0.05 relative other polyplex plexes formed in water (B) or 150 mm NaCl (C) were 
conditions. incubated on the substrate for 120 min. Images were cap- 
FIG. 19 shows transgene expression by substrate-medi- 35 tured after washing the substrate with PBS buffer. 
ated delivery. (A, B) Polyplexes and (C, D) lipoplexes with FIG. 28 shows spatially controlled gene transfer of NIHI 
plasmid encoding for luciferase were incubated on sub- 3T3 cells plated on topographically patterned HA-collagen- 
strates at low (0.5 pg; A, C) and high (2.0 pg; B, D) doses NA hydrogels with immobilized DNMPEI complexes. 
for 2 hours. Bolus delivery used equivalent amounts of DNA Overlay of GFP positive cells and rhodamine phalloidin 
that were immobilized to the substrate: (A) 0.2 pglcm2, (B) 40 staining are shown. Magnifications correspond to 100x(A) 
0.5 pglcm2, (C) 0.25 pglcm2 and (D) 0.1 pglcm2. Activity and 200x(B). 
was normalized to the number of cells seeded. Data is FIG. 29 shows transgene expression in NIH/3T3 cells 
presented as average +standard deviation of the mean. * mediated by immobilized complexes to HA-collagen-NA 
indicates pe0.05 relative to other delivery methods for that substrates. % biotinylated pEI indicate the percent biotiny- 
condition. ** indicates pe0.05 at different complex condi- 45 lation of the complexes, The symbols * and ** represents a 
tions. statistically significant level of pe0.05 and e0.01; respec- 
FIG. 20 shows transfected cell numbers by substrate- tively, for single comparisons between biotinylated com- 
mediated delivery. Lipoplexes with plasmid encoding for plexes and non-biotinylated complexes. Complexes were 
GFP were incubated on substrates with quantities of (A) 0.5 formed at an NIP ratio of 5. Plotted data is an average of 
pg and (B) 2 pg for 2 hours. Bolus delivery used equivalent 50 triplicate conditions. 
amounts of DNA that were immobilized to the substrate: (A) FIG. 30 shows GFP transgene expression in NIH/3T3 
0.25 pgIcm2 and (B) 0.1 pgIcm2. Data is presented as cells mediated by immobilized complexes to HA-collagen- 
average +standard deviation of the mean. * indicates pe0.05 NA substrates. The cell nuclei are stained with HOESCHT 
relative to the other delivery methods for that condition. dye for visualization (A). The percentage of transfected cells 
FIG. 21 shows release of adsorbed complexes upon 55 was calculated by dividing the number of GFP positive cells 
exposure to conditioned media. Polyplexes (circles) and by the total number of nuclei. The symbol *** represents a 
lipoplexes (triangles) (2 pg) were adsorbed to (A) PS and (B) statistically significant level of pe0.0001 for a single com- 
FBS-PS substrates and exposed to conditioned media at 37' parison between large and small complexes. Complexes 
C. Data is presented as average +standard deviation of the were formed at an NIP ratio of 5. Plotted data is an average 
mean. Data points at 0.5 days and above are at pe0.05 60 of triplicate conditions. 
relative to delivery with the other vector at each time point FIG. 31 shows release kinetics of biotinylated and non- 
for each surface. biotinylated complexes immobilized to HA-collagen-NA 
FIG. 22 shows distribution of cells and polyplexes on hydrogels against PBS (A), conditioned media (B) or hyalu- 
substrate following cell culture. Confocal microscopic ronidase (C). Complexes containing 0% and 25% biotiny- 
images of polyplexes on (A) PS and (B) FBS-PS 20 hours 65 lated PEI were immobilized to the hydrogel substrates. The 
after cell seeding. Polyplexes (2 pg, NlP=25) was incubated symbols * and *** represents a statistically significant level 
on substrates for 2 hours. Images captured 20 hours after cell of pe0.05 and ~0.001;  respectively, for single comparisons 
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between biotinylated complexes and non-biotinylated com- of being internalized by a cell in the nucleic acid-polylinker 
plexes. Plotted data is an average of triplicate conditions. complex of the invention. The internalized nucleic acid may 
FIG. 32 shows luciferase transgene expression in NIHI encode a protein, a growth factor, a hormone, etc., or may be 
3T3 cells mediated by immobilized complexes to HA- an antisense oligonucleotide which interferes with the 
collagen-NA substrates for cells durectly attached to the 5 expression of a gene. The instant invention provides a 
hydrogel (open diamonds) or not in contact with the hydro- condensed nucleic acid in the form of a nucleic acid- 
gel (closed diamonds). % biotinylated PEI indicate the polylinker complex immobilized on the surface of a support 
percent biotinylation of the complexes. All complexes were substrate; the complex is released from the surface of the 
formed at an NIP ratio of 5. Plotted data are an average of support subtrate into the cell microenvironment, and is 
triplicate conditions. 10 capable of being internalized by the cell. As shown in the 
FIG. 33 shows luciferase transgene expression in NIHI experiments reported below, a cell taking up the released 
3T3 cells mediated by immobilized complexes to HA- complex is transformed and able to express the transgene of 
collagen-NA substrates. % RGD-PEI indicates the percent the internalized complex. 
RGD modification of the complexes. DNMPEI complexes The terms "support substrate", "solid substrate", "solid 
were formed (NIPF5) with mixtures of three types of PEI: 15 support", "support" and "supporting scaffold" are used inter- 
biotinylated, RGD-modified and unmodified. The percent- changeably and represent a material that binds a polylinker 
age of biotinylated PEI was kept constant at 25% and the which is complexed with a nucleic acid, which provides a 
percentage of RGD-PEI was varied from 0% to 75% to surface for a cell to interact with the nucleic acid associated 
obtain different quantities of RGD in the complex. Plotted with the solid substrate, and which is biocompatible, e.g., 
data is an average of triplicate conditions. 20 non-toxic, to cells. 
FIG. 34 shows photomicrographs of GFP expressing cells The solid substrate may contain, or can be chemically 
in patterns on gold surfaces. a) Overlay of GFp photomi- modified to contain a functional group that allows the solid 
crograph on phase photomicrograph. b) Photomicrograph of substrate to covalently bind to a bifunctional polylinker. 
just GFP-expressing cells. Examples of material that can be used as solid substrates 
FIG. 35 shows luciferase transgene expression in NIHI 25 include glass, peptide polymers (e.g., collagen), HA-col- 
3T3 cells mediated by immobilized complexes to lagen hydrogel, peptoid polymers, pol~saccharides (includ- 
alkanethiol modified gold surfaces. DNA was complexed ing ~~mmerc ia l  beads, e.& SI3PHADEX and the like), 
with Lipofectamine, deposited onto gold for 2 hours, sur- carbohydrates, hydrophobic polymers, polymers, tissue cul- 
faces were washed and cells were then seeded. Luciferase ture polystyrene, planar lipid layers, planar lipid bila~ers, 
expression was assayed for 24 hours later. 30 metals, derivatized plastic films, glass beads, plastic beads, 
alumina gels, magnetic beads, nitrocellulose, cellulose, 
DETAILED DESCRIPTION OF THE nylon membranes, cotton, and glass wool. 
INVENTION The term "bifunctional agent" is used interchangeably 
with "bifunctional cross-linker" and is a compound that 
Before the present methods and compositions are 35 comprises two chemically reactive groups such as a thiol, an 
described, it is to be understood that this invention is not amine, aketone, or an aldehyde, or a pair of binding Partners 
limited to particular methods, compositions, and experimen- such biotin-streptavidin, biotin-avidin, antibody-antigen, 
tal conditions described, as such methods and compounds and receptor-ligand. Particular bifunctional cross-linkers are 
may vary, ~t is also to be understood that the terminology exemplified in FIG. 6. Bifunctional cross-linkers are used in 
used herein is for the purpose of describing particular 40 the present invention in one embodiment to covalently bind 
embodiments only, and is not intended to be limiting, since a ~ ~ l ~ l i n k e r  to a support substrate, in which one end of the 
the scope of the present invention will be limited only the bifunctional cross-linker is covalently attached to a reactive 
appended claims. group on the substrate and the other end is covalently bound 
As used in this specification and the appended claims, the to the polylinker. See FIG. 5 as an example of modification 
singular forms and "them include plural references 45 of the surface support and DNA tethering or immobilization. 
unless the context clearly dictates otherwise. Thus for The terms "polylinker" or "accessory molecule", are used 
example, references to polylinkerm includes mixtures of herein interchangeably to define a polymer or other cationic 
such polylinkers, reference to ''the formulationm or "the compound that can act to complex with and condense the 
method'' includes one or more formulations, methods, and molecule of interest, e.g., a nucleic acid, and immobilize it 
or steps of the type described herein andor which will 50 on or tether it to a solid substrate. Examples of polylinkers 
become apparent to those persons skilled in the art upon include cationic polymers, cationic ~ e ~ t i d e s ,  cationic Pep- 
reading this disclosure and so forth. toids, or cationic compounds such as cationic lipids. 
unless defined otherwise, all technical and scientific AS used herein a "tether" is a bond that covalently or 
terms used herein have the same meaning as commonly ~~o~~-covalently attaches an accessory molecule to the solid 
understood by one of ordinary skill in the art to which this 55 substrate, either directly or through a bifunctional cross- 
invention belongs, ~ l ~ h ~ ~ ~ h  any methods and materials linker. Preferably, this bond is reversible andor can be 
similar or equivalent to those described herein can be used broken 
in the practice or testing of the present invention, the AS used herein the term "condensed nucleic acid" is a 
preferred methods and materials are now described. ~ 1 1  n~cleic acid (e.g., a DNAplasmid or an oligonucleotide) that 
publications mentioned herein are incorporated herein by 60 is non-covalently associated with accessory molecules 
reference to disclose and described the methods andor a (see below). Examples 
in connection with which the publications are of condensing agents include cationic polymers, cationic 
cited. lipids and polycations. 
As used herein the term a "molecule of interest" is a 
Definitions 65 molecule that is tethered to a solid support for use in the 
By the term "nucleic acid", "gene", or the like, is meant methodology disclosed by the present invention. Such mol- 
a polynucleotide such as a plasmid, DNA, or RNA capable ecules of interest include nucleic acids such as a DNA 
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(preferably a plasmid), an oligonucleotide, or a modified nism can be adapted to biomaterial surfaces, such as PLG, 
oligonucleotide (e.g., phosphorothioate). which is commonly used for biomedical applications such as 
As used herein the term "polyplex" refers to a nucleic acid tissue engineering. 
that is complexed with cationic polymers, such as, but not Reverse transfection and substrate-mediated delivery are 
limited to, polyethylenimine (PEI). 5 based on the immobilization of DNA complexes to the 
As used herein, the term "lipoplex" refers to a nucleic acid culture substrate, which has been achieved by several meth- 
that is complexed with a lipid, such as, but not limited to, the ods. Ziauddin and Sabatini deposit naked DNA followed by 
cationic lipid Lipofectamine 2000. addition of a cationic lipid. Plasmid DNA is suspended in 
As used herein, immobilizing a nucleic acid to the cell gelatin and spotted onto a slide, which is followed by lipid 
culture substrate prior to cell seeding has been termed 10 addition to the culture media. Substantial transfection of 
"substrate-mediated delivery" or "solid phase delivery". HEK 293 cells was observed using this approach (Ziauddin 
"NIP" refers to the ratio of nitrogen to phosphorous. and Sabatini 2001, Nature 411(6833): 107-lo), and may 
used herein, the term mediam refers to require some modification to transfect other cell types 
growth media collected from cells having been in culture for (Bailey et al. 2002, Drug Discov Today 7(18 Suppl):S113-8; 
at least 24 hours. The particular cells from which culture 15 WU et al. 2002, Trends Cell Biol 12(10):485-8). 
media was in the present studies were ~ 1 ~ 1 3 ~ 3  A" alternative to the DNMgelatin immobilization proce- 
cells. dure involves the complexation of plasmid with cationic 
used herein, of the support substratem lipids or polymers, which are then immobilized to the 
may be defined as any alteration in the surface characteris- substrate. Biotin residues have been attached to cationic 
tics of the substrate which may affect binding of the 20 polymers, which are then mixed with plasmid to facilitate 
such modifications may be chemical modifications specific binding of DNA complexes to an avidin-modified 
such as the covalent or non-covalent interactions described substrate (Segura and Shes 2002, BioconJug 13(3): 
herein. Alternatively, the modifications may refer to non- 621-9; Segura et al. 2003, J Control Release 93(1):69-84). 
chemical modifications that affect the binding of the Increasing the number of biotin residues enhanced substrate 
plexes to the substrate. For example, the use of serum for 25 binding, whereas maximal transfection of ~ ~ ~ 2 9 3  and 
modifications of the substrate may have a two-fold effect. In N1H13T3 was with few mmbers 
one case, the nitrogens from the proteins present in serum residues. However, complexes can be non-s~ecificall~ 
may alter the binding characteristics of the complex to the adsorbed to the substrate, likely through interactions 
substrate, ~ l t ~ ~ ~ t i ~ ~ l ~ ,  the serum may the surface between the cationic lipid or polymer and the substrate. 
of the substrate by altering the wettability, which in turn may 30 Complexes have been formed in the Presence of extra- 
affect the binding of the complexes to the cellular matrix components and dried onto the substrate 
substrate. (Yoshikawa et al. 2004, J Control Release 96(2):227-32). 
This approach transfected a variety of cell types, including 
General Description human mesenchymal stem cells. 
One aspect of the invention provides a nucleic acid- 35 The present invention provides for polyplex and lipoplex 
~ o l ~ l i n k e r  complex immobilized or tethered to a supporting binding to the substrate from solution, and the ability to 
substrate or scaffold, wherein a cell adhered onto the sup- trmsfect cell lines and primary hman-derived cells, all of 
porting substrate is capable of internalizing the nucleic acid these aspects having advantages over the existing methods, 
complex and expressing the protein enc~ded by the nucleic The studies presented herein have sought to characterize 
acid. 40 properties of the substrate and the complexes that mediate 
The approach involves forming a mn-covalent binding substrate immobilization and transgene expression. 
complex between the nucleic acid and the polylinker mol- Substrate immobilization of DNA complexes by adsorp- 
ecule. The polylinker molecules are b ~ u n d  to the solid tion results from non-covalent, nonspecific interactions 
substrate. The tethering of the complex serves to localize the between the substrate and complexes, and can depend upon 
nucleic acid to the surface, thus placing it directly into the 45 the molecular composition of both vector and substrate. 
cell microenvironment. Non-specific adsorption of proteins to surfaces has been 
The invention also provides for characterization of gene characterized by molecular interactions, which include 
transfer by DNA complexes adsorbed to tissue culture hydrophobic, electrostatic, and van der Waals interactions 
polystyrene and biomaterial substrates. Polyplexes and (Norde and Lyklema 1991, J Biomater Sci Polym Ed 2(3): 
lipoplexes were adsorbed to either unmodified (PS) or 50 183-202). DNA complex adsorption likely occurs through 
serum-adsorbed (FBS-PS) polystyrene. Complex immobili- similar mechanisms. Both lipoplexes and polyplexes adsorb 
zation to the substrate increased with time of exposure, and to the substrates, with at least 60% immobilized after 24 
the deposition rate and final amount deposited depended hour incubation. Substrate immobilization can prevent com- 
upon the properties of the substrate and complex. plex aggregation (Segura et al. 2003, J Control Release 
Polyplexes immobilized to FBS-PS provide greater trans- 55 93(1):69-84), maintain complexes at the surface during 
fection than polyplexes immobilized to PS, and equivalent wash steps, and may enhance complex stability. 
or greater transfection than "bolus" delivery of complexes, Maximal transfection from the substrate is hypothesized 
wherein the delivery of the nucleic acid complexes to cells to represent a balance between complex binding to the 
is accomplished all at one time. Moreover, there is greater substrate and cellular internalization. As shown herein, 
cytotoxicity associated with bolus delivery as compared to 60 transfection was observed with both polyplexes and 
the substrate-mediated approach. Lipoplexes, however, pro- lipoplexes adsorbed to serum modified and unmodified 
vide similar levels of transgene expression on serum coated polystyrene, suggesting that substrate-mediated delivery is 
and uncoated surfaces. Interestingly, transfection on serum applicable to a variety of transfection reagents and sub- 
coated surfaces increases the number of transfected cells strates. However, this cellular transfection by the immobi- 
relative to uncoated surfaces. Immobilized complexes are 65 lized DNA complexes was not equivalent across substrates 
able to transfect primary cells, and result in lower cytotox- and transfection reagents. Serum coating of polystyrene 
icity relative to bolus delivery. Finally, this delivery mecha- could enhance transgene expression (polyplexes) or the 
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percentage of transfected cells (lipoplexes). These differ- Hyaluronic Acid-Collagen Hydrogels for DNA Delivery via 
ences in the transfection profile do not reflect substantial a Substrate Mediated Approach 
differences in the amount of DNA immobilized (FIG. la),  Another aspect of the invention provides a substrate 
and may result from differences in cellular internalization mediated strategy for delivering DNA complexes from 
from the substrate. Conditions with relatively low transfec- 5 hyaluronic acid-collagen hydrogels. Hydrogels were formed 
tion had DNA bound to the substrate, whereas conditions by crosslinking HA with poly(ethy1ene glycol) diglycidyl 
with higher transfection showed less substrate-associated ether, and a topography was introduced using pattern trans- 
DNA and more cell-associated DNA (FIG. 22). Addition of fer. DNMPEI complexes of varied sizes were immobilized 
conditioned media to the substrates significantly enhanced to the hydrogel substrate using biotidneutravidin binding 
release of the complexes relative to incubation with PBS. A l o  and non-specific adsorption. 
cellular product, such as proteases, may promote release of Manipulating complex properties for substrate mediated 
the complexes from the substrate. The mechanism of cellular delivery can be employed to regulate the transfection profile 
internalization from the substrate, and DNA distribution (number of transfected cells, transgene expression). Com- 
among the cell populations are the focus of continuing plex size was modulated by forming complexes in the 
studies. 15 absence or presence of salt. Large complexes increased the 
Maximal transgene expression for polyplexes and extent of transgene expression relative to small complexes, 
lipoplexes by substrate-mediated delivery is similar, yet the whereas small complexes increased the number of trans- 
transfection profile and dependence on the substrate prop- fected cells relative to large complexes. The aggregation of 
erties reflect differences in composition and intrinsic trans- complexes in solution has limited the ability to correlate 
fection properties. Polyplexes and lipoplexes have substan- 20 transfection to complex size at a specific NIP ratio (Hag- 
tially different z-average diameters, zeta-potential, and strom J E., Curr Opin Mol Ther 2000;2(2): 143-9; Ogris M, 
chemical composition. Increasing the NIP ratio for poly- Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E., 
plexes increases their zeta potential and reduces their size Gene Ther 1998;5(10):1425-33; Ogris M, Steinlein P, 
(Boussif et al. 1995, Proc Natl Acad Sci USA 92(16): Carotta S, Brunner S, Wagner E., AAPS PharmSci 2001;3 
7297-301; Choosakoonkriang et al. 2003, J Pharm Sci 25 (3):E21). Cationic polymerlDNA (e.g., DNMPEI) com- 
92(8):171&22; Ogris et al. 2001, AAPS PharmSci 3(3): plexes aggregate in polyelectrolyte solutions (150 mm 
E21). Conversely, altering the composition of lipoplexes has NaCl) (Goula D, Remy J S, Erbacher P, Wasowicz M, Levi 
less marked effects on the complex diameter and zeta- G, Abdallah B, et al., Gene Ther 1998;5(5):712-7; Plank C, 
potential (FIG. 15). An increasing NIP ratio decreases bind- Tang M X, Wolfe A R, Szoka Jr F C., Hum Gene Ther 
ing of polyplexes to PS and has no effect on FBS-coated PS. 30 1999;10(2):319-32; Trubetskoy V S, Loomis A, Slattum P 
As shown herein, for a 2 hour deposition, polyplexes bind M, Hagstrom J E, Budker V G, Wolff J A,, Bioconjug Chem 
more effectively than lipoplexes, with a difference of 1999;10(4):624-8), andor in solutions containing serum 
approximately 16%. Polyplex delivery from serum-modified proteins such as albumin, fibronectin, and fibrinogen (Ogris 
substrates could increase transgene expression relative to M, Brunner S, Schuller S, Kircheis R, Wagner E., Gene Ther 
delivery from PS and to equivalent quantities delivered as a 35 1999;6(4):595-605; Lucas P, Milroy D A, Thomas B J, Moss 
bolus. However, lipoplex delivery yields similar levels of S H, Pouton C W, J Drug Target 1999;7(2):143-56; Oupicky 
expression across delivery methods. Interestingly, D, Howard K A, Konak C, Dash P R, ulbrich K, Seymour L 
lipoplexes increase the number of transfected cells relative W., Bioconjug Chem 2000; 11 (4):492-501; Xu B, Wiehle S, 
to polyplex delivery, and produce the greatest percentage of Roth J A, Cristiano R J., Gene Ther 1998;5(9):1235-43). 
transfected cells by delivery from serum-coated substrates. 40 Strategies to stabilize complex size in solution involve steric 
Immobilization of DNAcomplexes by adsorption can be stabilization (Ogris M, Steinlein P, Carotta S, Brunner S, 
extended to biomaterials for applications such as tissue WagnerE.,AAPS PharmSci2001;3(3):E21; GoulaD, Remy 
engineering. Porous PLG or collagen scaffolds have been J S, Erbacher P, Wasowicz M, Levi G, Abdallah B, et al., 
fabricated with encapsulated polyplexes or lipoplexes, Gene Ther 1998;5(5):712-7; Ogris M, Brunner S, Schuller 
which have achieved substantial transfection in vitro (Co- 45 S, Kircheis R, Wagner E., Gene Ther 1999;6(4):595-605; 
hen-Sacks et al. 2004, J Control Release 95(2):309-20; Xu B, Wiehle S, Roth J A, Cristiano R J., Gene Ther 
Huang et al. 2003, J Biomed Mater Res 67A(4): 1384-92; 1998;5(9):123543; Wolfert M A, Dash P R, Nazarova 0, 
Scherer et al. 2002, J Gene Med 4(6):634-43) and in vivo Oupicky D, Seymour L W, Smart S, et al., Bioconjug Chem 
(Scherer et al. 2002, J Gene Med 4(6):634-43.). The pres- 1999;10(6):993-1004; Toncheva V, Wolfert MA, Dash P R, 
ence of the cationic lipid or polymer can significantly alter 50 Oupicky D, Ulbrich K, Seymour L W, et al., Biochim 
the release profile compared to plasmid DNA. The biotin- Biophys Acta 1998;1380(3):354-68), caging (Trubetskoy V 
avidin interaction has been used to bind both viral and S, Loomis A, Slattum P M, Hagstrom J E, Budker V G, Wolff 
non-viral vectors to a variety of materials (Levy et al. 2001, J A,, Bioconjug Chem 1999;10(4):624-8; Adami R C, Rice 
Gene Ther 8(9):659-67; Segura et al. In Press). Alterna- K G., J Pharm Sci 1999;88(8):739-46), and anionic poly- 
tively, complexes formed with polyamidoamine (PAMAM) 55 merlDNAparticles (Trubetskoy V S, Budker V G, Hanson L 
dendrimers have been dried onto PLG and collagen mem- J, Slattum P M, Wolff J A, Hagstrom J E., Nucleic Acids Res 
branes coated with phosphatidyl glycerol (1-5%) (Bielinska 1998;26(18):4178-85; Trubetskoy V S, Loomis A, Hag- 
et al. 2000, Biomaterials 21(9):877-87). In vitro transfection strom J E, Budker V G, Wolff J A,, Nucleic Acids Res 
was comparable to bolus controls, while in vivo delivery 1999;27(15):3090-5). The increase in complex size with 
enhanced expression six to eight-fold relative to plasmid 60 time in the presence of salts andor serum proteins has been 
delivery. Alternatively, plasmid DNA has also been incor- hypothesized to result from increased inter-complex inter- 
porated into inorganic calcium phosphate co-precipitates actions, which create bridges between complexes (Hagstrom 
that are adsorbed onto PLGA matrices, which are mostly J E., Curr Opin Mol Ther 2000;2(2): 143-9). Nevertheless, 
released by 48 hours (Kofron and Laurencin 2004, Bioma- transfection results obtained here are consistent with a 
terials 25(13):2637-43). The present invention demonstrates 65 previous report showing large complexes (600 nm) achieved 
the ability to adsorb complexes to PLG to obtain significant up to 500 fold greater luciferase expression than small 
transfection on the substrate. complexes (60 nm); however, the percentage of transfected 
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cells was less substantial between large complexes and small tive protein adsorption. Although approximately 50% of 
complexes (Ogris M, Steinlein P, Kursa M, Mechtler K, DNMPEI complexes are released in conditioned media after 
Kircheis R, Wagner E., Gene Ther 1998;5(10): 1425-33). 48 h, gene transfer at 48 h was only observed in cells that 
The dependence of the transfection profile on complex size were directly attached to the hydrogel substrate (FIG. 32). 
has been attributed to mass transport to the cell surface, and 5 The transfection of cells cultured on the hydrogel, but not 
altered endosomal release (Ogris M, Steinlein P, Kursa M, incubated with the hydrogel, likely results from an elevated 
Mechtler K, Kircheis R, Wagner E., Gene Ther 1998;5(10): concentration in the cellular microenvironment. For cells 
1425-33). For substrate-immobilization, mass transport cultured with the hydrogel, released complexes may be 
limitations are likely insignificant and thus the transfection deactivated (e.g., aggregation) prior to cellular internaliza- 
profile would be affected by endosomal release. Enhanced l o  tion, or mass transport limitations may minimize cellular 
transgene expression for the large complexes may result uptake (Luo D, Saltzman W M., Nat Biotechnol 2000;lX 
from an increased content of DNA and PEI per complex, (8):893-5). 
which can facilitate endosomal escape and increase the The presence of RGD peptides in the DNA complex, 
probability of DNA transport to the nucleus. Furthermore, which was hypothesized to increase cellular binding to the 
these results suggest that small complexes are more effec- 1s complexes through integrin receptors, resulted in lower 
tively internalized resulting in larger numbers of transfected transgene expression than unmodified complexes. The 
cells, but are not as effectively transported through the cell modification of cationic polymers with receptor ligands such 
and thus lower transgene expression. In the present inven- as transferrin (Kircheis R, Kichler A, Wallner G, Kursa M, 
tion, immobilization of DNA complexes to the substrate Ogris M, Felzmann T, et al., Gene Ther 1997;4(5):409-la), 
occurred through non-specific adsorption and biotin-neutra- 20 RGD (Kunath K, Merdan T, Hegener 0, Haberlein H, Kissel 
vidin (NA) binding. Non-specific adsorption of proteins to T.; J Gene Med 2003;5(7):588-99; Harbottle R P, Cooper R 
surfaces occurs through a variety of interactions, such as G, Hart S L, Ladhoff A, McKay T, Knight AM,  et al., Hum 
hydrophobic, electrostatic, and van der Waals (Norde W, Gene Ther 1998;9(7): 103747), and galactose (Plank C, 
Lyklema J., J Biomater Sci Polym Ed 1991;2(3):183-202). Zatloukal K, Cotten M, Mechtler K, Wagner E., Bioconjug 
The adsorption of DNA complexes likely occurs through 25 Chem 1992;3(6):533-9; Kunath K, von Harpe A, Fischer D, 
similar mechanisms, and is hypothesized to depend on the Kissel T., J Control Release 2003;88(1):159-72), enhance 
molecular composition of the vector (e.g., cationic polymer) binding and internalization for complexes delivered as a 
and substrate. Cationic polymers such as polylysine and PEI bolus. Reduced transgene expression with ligand-modified 
have been used to coat tissue culture plastic for in vitro complexes has been seen previously for complexes with a 
studies, and PEIIDNA complexes interact with serum pro- 30 net positive charge (Kunath K, Merdan T, Hegener 0, 
teins (Ogris M, Brunner S, Schuller S, Kircheis R, Wagner Haberlein H, Kissel T., J Gene Med 2003;5(7):588-99; 
E., Gene Ther 1999;6(4):595-605; Lucas P, Milroy D A, Kircheis R, Kichler A, Wallner G, Kursa M, Ogris M, 
Thomas B J, Moss S H, Pouton C W., J Drug Target Felzmann T, et al., Gene Ther 1997;4(5):409-18; Harbottle 
1999;7(2): 143-56; Oupicky D, Howard K A, Konak C, R P, Cooper R G, Hart S L, Ladhoff A, McKay T, Knight A 
Dash P R, Ulbrich K, Seymour L W., Bioconjug Chem 35 M, et al., Hum Gene Ther 1998;9(7):1037-47; Plank C, 
2000;11(4):492-501; Xu B, Wiehle S, Roth J A, Cristiano R Zatloukal K, Cotten M, Mechtler K, Wagner E., Bioconjug 
J. The contribution of poly L-lysine, epidermal growth Chem 1992;3(6):533-9; Kunath K, von Harpe A, Fischer D, 
factor and streptavidin to EGFIPLLIDNA polyplex forma- Kissel T., J Control Release 2003;88(1): 159-72). For sub- 
tion. Gene Ther 1998;5(9): 1235-43). Previous reports dem- strate-mediated delivery, transgene expression decreased by 
onstrated that the presence of biotin groups in the complex 40 an order of magnitude for complexes formed with 0% and 
resulted in substantially increased binding to the NA-coated 75% RGD-PEI, respectively. To our knowledge, this reduc- 
polystyrene substrate and transgene expression compared tion in transgene expression as RGD content is increased at 
with nonbiotinylated complexes (Segura T, Shea L D., a fixed NIP has not been previously reported. A reduction in 
Bioconjug Chem 2002;13(3):621-9; Segura T, Volk M J, transgene expression with the presence of RGD peptides 
Shea L D, J Control Release 2003;93(1):69-84). AS shown 45 suggests that cellular interactions with the complex are not 
herein, biotin residues have no significant effect on binding a factor limiting transgene expression. 
to the substrate, while DNA release and transgene expres- Reduction in transgene expression with increased RGD 
sion are only moderately enhanced. For release in condi- content may result from the RGD peptide affecting intrac- 
tioned media and hyaluronidase, biotinylated complexes had ellular transport or reduced complex internalization as a 
an increased release (El 5%) after 8 days with no significant 50 result of multiple cellular interactions occurring per com- 
effect at earlier times. Transgene expression, which is ana- plex, which could limit internalization. Biomaterial scaf- 
lyzed at two days, is enhanced by a factor of 2 or less with folds that support cell adhesion and are capable of efficient 
biotinylated complexes. These observations regarding in gene delivery can provide a fundamental tool for localized 
vitro binding, release, and transfection suggests that immo- transgene expression, which can stimulate and direct cellular 
bilization primarily occurs by non-specific interactions 55 processes that lead to tissue formation. The scaffold is 
between the DNMPEI complexes and the substrate. Release typically biodegradable, functions to create and maintain a 
studies of the immobilized complexes in different release space for tissue formation, provides a support for cell 
mediums indicate that complexes are released during incu- adhesion and migration, and allows integration of the regen- 
bation, and that released complexes transfect only cells that erating tissue with the host (Murphy W L, Mooney D J., J 
are adhered to the substrate. Immobilization of DNA com- 60 Periodontal Res 1999;34(7):413-9). DNA delivery from the 
plexes occurred through complexes interacting with the scaffold frequently targets infiltrating fibroblasts, which can 
substrate, which contained NA (biotinylated complexes serve as bioreactors for the localized production of tissue 
only), HA, and collagen. Hyaluronidase treatment would inductive factors (Bonadio J, Smiley E, Patil P, Goldstein S., 
release DNA by degrading the HA backbone, the primary Nat Med 1999;5(7):753-9). Several strategies employ bio- 
component of the substrate. Alternatively, conditioned 65 materials to provide a sustained release of DNA or DNA 
media contains serum proteins and other cellular products complexes (Pannier A K, Shea L D. Mol Ther, in press.); 
that could induce release enzymatically or through competi- however, DNA complexes can also be immobilized to 
concentrate the DNA at the biomaterial surface and prevent hybridizing nucleic acid, the more base mismatches with an 
distribution to non-target tissues. The present invention RNA it may contain and still form a stable duplex (or triplex, 
demonstrates a strategy to immobilize DNAto hydrogels for as the case may be). One skilled in the art can ascertain a 
delivery to adherent cells, with the properties of the immo- tolerable degree of mismatch by use of standard procedures 
bilized complexes regulating the transfection profile (trans- 5 to determine the melting point of the hybridized complex. 
gene expression, number of transfected cells). The appro- In another embodiment, the nucleic acid of interest is a 
priate expression profile will likely depend upon the ribozyme or triple helix molecule used to modulate the 
physiological system and gene of interest. For example, activity, expression or synthesis of the gene present in the 
transplanting engineered cells that secrete low levels of cell. Techniques for the production and use of such mol- 
vascular endothelial growth factor (VEGF) produced a l o  ecules are well known to those of skill in the art. 
mature vascular network, which was not observed by trans- Ribozyme molecules designed to catalytically cleave 
plantation of cells secreting high levels of VEGF (Ozawa C gene mRNA transcripts can be used to prevent translation of 
R, Ban. A, Glazer N L, Thurston G, Springer M L, Kraft P target gene mRNA and, therefore, expression of the gene 
E, et al., J Clin Invest 2004;113(4):516-27). For genes that product. (See, e.g., PCT International Publication W0901 
act intracellularly, such as tumor suppressor genes or tran- 1s 11364, published Oct. 4, 1990; Sarver et al. (1990) Science 
scription factors, the delivery system must transfect large 247:1222-1225). 
numbers of cells (Braddock M., Ann Med 2001;33(5): Ribozymes are enzymatic RNA molecules capable of 
313-8; Scholl S M, Michaelis S, McDermott R., J Biomed catalyzing the specific cleavage of RNA. (For a review, see 
Biotechnol 2003;2003(1):35-47). The present invention Rossi (1994) Current Biology 4, 469-471). The mechanism 
also demonstrates that immobilization enables spatial pat- 20 of ribozyme action involves sequence specific hybridization 
terning of gene transfer by transfecting cells that attach and of the ribozyme molecule to complementary target RNA, 
orient along a topographical pattern. The engineering of followed by an endonucleolytic cleavage event. The com- 
tissue structures, such as the intricate networks of the position of ribozyme molecules must include one or more 
vascular and nervous systems, will require methods for sequences complementary to the target gene mRNA, and 
controlling the physical placement of molecular signals 25 must include the well known catalytic sequence responsible 
(Saltzman W M, Olbricht W L., Nat Rev Drug Discov for mRNA cleavage. For this sequence, see, e.g., U.S. Pat. 
2002;1(3):177-86). The ability to spatially regulate gene No. 5,093,246, which is incorporated herein by reference in 
delivery on the scaffold can be employed to create spatial its entirety. 
gradients in the expression of various tissue inductive fac- While ribozymes that cleave mRNA at site specific rec- 
tors (e.g., growth factors, matrix molecules), which are 30 ognition sequences can be used to destroy mRNAs, the use 
characteristic of many developing tissues. Opportunities for of hammerhead ribozymes is preferred. Hammerhead 
spatially controlled gene delivery include directing neurite ribozymes cleave mRNAs at locations dictated by flanking 
outgrowth, or orienting cell growth for tissues such as regions that form complementary base pairs with the target 
muscle. This spatial control of cell attachment and transfec- mRNA. The sole requirement is that the target mRNA have 
tion can be a powerful tool with broad applicability to tissue 35 the following sequence of two bases: 5'-UG-3'. The con- 
engineering. struction and production of hammerhead ribozymes is well 
Nucleic Acids known in the & and is described more fully in Myers (1995) 
Molecular Biology and Biotechnology: A Comprehensive 
The present invention therefore utilizes condensed 
nucleic acids in a complex with polylinkers, wherein the Desk Reference, VCH Publishers, New York, (see especially 
polylinkers or a percentage thereof, are covalently andor 
40 FIG. 4, page 833) and in Haseloff and Gerlach (1988) 
Nature, 334, 585-591, each of which is incorporated herein 
non-covalently bound to the surface of the support substrate. by reference in its entirety. 
In one such embodiment the nucleic acid is a DNA mol- 
Preferably the ribozyme is engineered so that the cleavage 
ecule. In a more specific embodiment, the DNAmolecule is 
recognition site is located near the 5' end of the mRNA to a plasmid. In a related embodiment the DNA molecule 
45 increase efficiency and minimize the intracellular accumu- 
encodes a protein. In another embodiment the nucleic acid 
lation of non-functional mRNA transcripts. is an oligonucleotide, and in specific embodiments, the 
The ribozymes of the present invention also include RNA 
oligonucleotide is an antisense molecule, a ribozyme, or a 
endoribonucleases (hereinafter "Cech-type ribozymes") 
triple helix molecule. such as the one that occurs naturally in Tetrahymena ther- 
Antisense. Ribozvmes. and Trivle Helix Molecules 50 movhila (known as the IVS. or L-19 IVS R N A ) ; ~ ~  that has 
2 ,  . , 
The antisense nucleic acids of the invention comprise a been extensively described by Thomas Cech and collabora- 
sequence complementary to at least a portion of an RNA tors (Zaug, et al. (1984) Science, 224, 574-578; Zaug and 
transcript of a gene, however, absolute complementarity, Cech (1986) Science, 231, 470475; Zaug, et al. (1986) 
although preferred, is not required. A sequence "comple- Nature, 324, 429-433; published International patent appli- 
mentary to at least a portion of an RNA," as referred to 55 cation No. WO 88104300 by University Patents Inc.; Been 
herein, means a sequence having sufficient complementarity and Cech (1 986) Cell, 47, 207-216). The Cech-type 
to be able to hybridize under stringent conditions (e.g., 
highly stringent conditions comprising hybridization in 7% 
sodium dodecyl sulfate (SDS), 1 mM EDTA at 65' C. and 
washing in O.lxSSCIO.l% SDS at 68' C., or moderately 
stringent conditions comprising washing in 0.2xSSCIO.l% 
SDS at 42" C. with the RNA, forming a stable duplex; in the 
case of double-stranded antisense nucleic acids, a single 
strand of the duplex DNA may thus be tested, or triplex 
formation may be assayed. The ability to hybridize will 
depend on both the degree of complementarity and the 
ribozymes have an eight base pair active site which hybrid- 
izes to a target RNA sequence whereafter cleavage of the 
target RNA takes place. The invention encompasses those 
60 Cech-type ribozymes which target eight base-pair active site 
sequences that are present in the gene of interest. 
As in the antisense approach, the ribozymes can be 
composed of modified oligonucleotides (e.g., for improved 
stability, targeting, etc.) and should be delivered to cells that 
65 express the gene of interest in vivo. A preferred nucleic acid 
for delivery involves using a DNA construct "encoding" the 
length of the antisense nucleic acid. Generally, the longer the ribozyme under the control of a strong constitutive pol I11 or 
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pol I1 promoter, so that transfected cells will produce suf- FIG. 2). Sulfo-KMUS, SPDP, SATA, SVSB, and Sulfo- 
ficient quantities of the ribozyme to destroy endogenous SIAB react with primary amines at one reactive center and 
mRNA encoding the protein of interest and inhibit transla- sulfhydryl groups at the other reactive center. Sulfo-NHS- 
tion. Because ribozymes, unlike antisense molecules, are LC-ASA contains two reactive centers that react with pri- 
catalytic, a lower intracellular concentration is required for 5 mary amines. The reactions at either end of this cross-linker 
efficacy. are independent since the reaction involving the azidosali- 
Alternatively, the endogenous expression of an encoding cylamido group is activated by ultraviolet light. TFC reacts 
gene of interest can be reduced by targeting deoxyribonucle- with primary amino groups at one of its reactive centers and 
otide sequences complementary to the regulatory region of activated carboxylic acids at its other reactive center. NHS- 
the gene (i.e., the gene promoter andor enhancers) to form 10 biotin, PFP-Biotin, and NHS-PC-LC-Biotin only have one 
triple helical structures that prevent transcription of the reactive center that reacts with amino groups, whereas, the 
encoding gene of interest (See generally, Helene (1991) natural binding of biotin to streptavidin is employed as the 
Anticancer Drug Des. 6(6), 569-584; Helene et al. (1992) second reactive center. NHS-PC-LC-Biotin is unique 
Ann. N.Y. Acad. Sci., 660, 27-36; and Maher (1992) Bio- because when it is exposed to ultraviolet light it releases the 
assays 14(12), 807-815). 15 original primary m i n e  containing the molecule. 
Nucleic acid molecules to be used in triplex helix forma- 
tion for the inhibition of transcription in the present inven- 
Polylinkers 
tion should be single stranded and composed of deoxynucle- A~O1~ l inke r  is for with the 
otides, The base composition of these oligonucleotides must of interest, e.g., a nucleic acid. In different embodiments, the 
be designed to promote triple helix formation via Hoogsteen 20 qolylinker is a cationic polymer, a cationic protein Or pep- 
base pairing rules, which generally require sizeable stretches tide, Or a cationic lipid. The polylinkers of the present 
of either purines or pyrimidines to be present on one strand invention function to form a complex with the molecule of 
of a duplex, Nucleotide sequences may be pyrimidine-based, interest, and the the surface the 
which will result in TAT and CGC+ triplets across the three The polylinker may be bound to 
associated strands of the resulting triple helix, The pyrimi- 25 the substrate. In a particular the percent- 
dine-rich molecules provide base complementarity to a age of polylinkers bound to the surface of the 
purine-rich region of a single strand of the duplex in a solid substrate is greater than 0.2%. In another embodiment, 
orientation to that strand, In addition, nucleic acid between 0.5-50% of the polylinkers are bound to 
molecules may be chosen that are purine-rich, for example, the surface of the solid substrate. In a more specific embodi- 
contain a stretch of G residues, These molecules will form 30 ment, between 1.0-25% of the polylinkers are 
a triple helix with a DNA duplex that is rich in GC pairs, in bound to the surface of the solid substrate. In a particular 
which the majority of the purine residues are located on a the between the polylinker and 
single strand of the targeted duplex, resulting in GGC the solid substrate is broken after a cell is plated on the solid 
triplets across the three strands in the triplex. substrate. 
Alternatively, the potential sequences that can be targeted 35 Cationic lipids: The main components of a cationic lipid 
for triple helix formation may be increased by creating a so are a h~d rO~h i l i c  ipid a linker group, and a posi- 
called "switchback" nucleic acid molecule, Switchback mol- tively headgroup. The lipid is 
ecules are synthesized in an alternating 5t-3t,3t-5t manner, either a fatty chain (e.g., derived from oleic or myristic acid) 
such that they base pair with first one strand of a duplex and Or a group, which determines the physical prop- 
then the other, eliminating the necessity for a sizeable stretch 40 erties of the lipid bilayer, such as flexibility and the rate of 
of either purines or pyrimidines to be present on one strand lipid exchange. The linker group is an determinant 
of a duplex. of the chemical stability, biodegradability, and transfection 
Antisense RNA and DNA, ribozyme, and triple helix efficiency of the cationic lipid. Biodegradable lipids can be 
metabolized by various enzymes (e.g., esterases, peptidases) molecules of the invention may be prepared by any method 
known in the art for the synthesis of DNA and RNA 45 to minimize any toxicity. The linker can also provide sites 
molecules, as discussed above. These include techniques for for the introduction of novel side chains to enhance target- 
chemically synthesizing oligodeoxyribonucleotides and oli- ing, uptake, and trafficking. The positively charged head 
goribonucleotides well known in the art such as for example group on the cationic lipid is responsible for interacting with 
solid phase phosphoramidite chemical synthesis. Alterna- the negatively charged DNA and is a critical determinant of 
tively, RNA molecules may be generated by in vitro and in 50 the transfection and cytotoxicity of liposome formulations. 
vivo transcription of DNA sequences encoding the antisense The headgroups differ markedly in structure and may be 
RNA molecule. Such DNA sequences may be incorporated single- or multiple-charged as primary, secondary, tertiary, 
into a wide variety of vectors that incorporate suitable RNA andor quaternary amines. The hydrophobicity of the lipid 
moiety has a crucial effect on in vitro gene transfer. Multi- polymerase promoters such as the T7 or SP6 polymerase 
promoters, Alternatively, antisense cDNA that 55 valent headgrou~s, such as 'permine, in a "T-sha~e" 'On- 
synthesize antisense RNA constitutively or inducibly, figuration tend to be more effective than their monovalent 
depending on the promoter used, can be introduced stably Counterparts at gene transfer. 
into cell lines. increases in the linker length correspond to increases in the 
gene delivery activity. Mixing of DNA and cationic lipid 
Bifunctional Cross-Linkers 60 results in the collapse of DNA to form a condensed struc- 
In one method of the invention, bifunctional cross-linkers ture-termed lipoplex-in which nucleic acids are buried 
are used as first and second functional groups to immobilize within the lipid. The thermodynamic driving force for asso- 
the nucleic acid-polylinker complex to the surface of the ciation of the DNA and lipid is the entropy increase from the 
support substrate. Bifunctional cross-linkers have two reac- release of counter ions and bound water associated with 
tive centers, which are generally at opposite ends of the 65 DNA and the lipid surface. 
cross-linker, e.g., a first and a second functional group, and The colloidal properties (e.g., size, stability) of the 
are used to bind two molecules together (see, for example, lipoplexes are principally determined by the cationic lipid 
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DNA charge ratio and not the composition of the lipid or the 
helper lipid. The charge ratio (+I-) is typically defined as the 
number of amines on the cationic lipid relative to the number 
of phosphate groups on the DNA. A neutral charge ratio (1 : 1 
charge ratio for 1ipid:DNA) should generally be avoided 
because it results in the formation of large aggregates (>1 
pM). Lipoplexes prepared at a positive charge ratio and a 
negative charge ratio likely represent structures with differ- 
ent lipid and DNA packaging (Xu et al. (1999) Biophys. J. 
77:341-353). At a positive charge ratio, large multilamellar 
vesicles (LMV, diameter 306700 nm) transfect cells more 
efficiently than the small unilamellar vesicles (SW,  diam- 
eter 50-200 nm) (Felgner et al. (1994) J. Biol. Chem. 
269:25562561; Turek et al. (2000) J. Gene Med. 2:3240; 
Ross and Hui (1999) Gene Ther. 6:65 1-659). The order in 
which DNA and lipid are mixed is critical and significantly 
affects the lipid and DNA packing (Xu et al. (1999) supra). 
For the addition of DNA to lipid, a gradual increase in size 
is observed. When adding lipid to DNA, the particle size 
remains roughly constant until the amount of lipid positive 
charge exceeds the nucleic acid negative charge, whereupon 
the particles grow rapidly in size (Kennedy et al. (2000) 
Biophys. J. 78: 1620-1633). 
The net charge on the lipoplex affects its interactions with 
other components present in vivo and in vitro (e.g., media, 
serum, extracellular matrix glycoproteins, mucosal secre- 
tions), which can limit the transfection efficiency. A positive 
charge ratio, which facilitates interactions with the cell 
membrane, is generally prefered for in vitro studies (3:1), 
whereas in vivo use may require the charge ratio to be 
altered because of interactions with components of the 
physiological environment. The charge ratio of the complex 
determines the zeta potential, which ranges from -55 mV to 
+55 mV as the charge ratio is increased. Multivalent anions 
present in the serum or media can facilitate fusion of the 
lipids causing an increase in the size of the particle. Polya- 
nions with adequate anionic charge density (e.g. heparin) 
released DNA from the complex by binding the cationic 
lipid. Serum can be a complicating factor for positively 
charged complexes, possibly causing premature release of 
the DNA from the complex and enhancing degradation by 
nucleases. For 0N:lipid complexes, the various components 
of serum (e.g., BSA, lipoproteins, and macroglobulin) inter- 
act with the complexes and alter the complex diameter, zeta 
potential, and interfere with cellular uptake and nuclear 
trafficking. 
To improve lipoplex stability, PEG-PE can be incorpo- 
rated into the cationic liposome. Such liposomes are pre- 
vented from aggregating and interacting with serum com- 
ponents, which increases their stability (Hong et al. (1997) 
FEBS Lett. 400:233-237; Meyer et al. (1998) J. Biol. Chem. 
273: 15621-15627). Alternatively, a detergent can be placed 
in solution with the cationic lipid and DNA (Hofland et al. 
(1996) Proc. Natl. Acad. Sci. USA 93:7305-7309). Removal 
of the detergent by dialysis allows the formation of uniform 
complexes. Lyophilization can also increase their shelf life. 
Cryoprotectants (e.g., sucrose, trehalose) also can be added 
to prevent aggregation and fusion of plasmidllipid com- 
plexes during lyophilization. 
Formulations of cationic lipids have been widely applied 
for in vitro nucleic acid transfection (see, for example, 
Felgner et al. (1987) Proc. Natl. Acad. Sci. USA 
84:7413-7417) and more than 30 products are commercially 
available for this purpose, including Lipofectin (a 1 : 1 mix- 
ture of DOTMA and DOPE), Transfectam, Lipofectase, 
Lipofect-AMINE, and LipoTaxi. Formulations of cationic 
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lipids can further contain a zwitterionic or neutral colipid, 
such as DOPE or cholesterol, to enhance transfection. 
Cationic Polymers: All cationic polymers contain high 
densities of primary amines, which are protonatable at 
neutral pH. This high density of positive charges allows the 
cationic polymers to form stable complexes with non-viral 
DNA. The cationic polymers self-assemble with DNA to 
generate condensed structures (46100 nm in diameter) 
capable of entering the cell. Cationic polymers include 
polyallylamine, peptoids, methacrylamide, and cyclodextrin 
containing polymers. Such polymers vary widely in their 
structure, which ranges from linear to highly branched 
molecules and influences their complexation with nucleic 
acids and their transfection efficiency. In addition to provid- 
ing positive charges for DNA complexation, the primary 
amines also serve as functional groups with which to chemi- 
cally modify the polymers with ligands and peptides that can 
enhance one or more of the steps in the transfection process. 
Poly-L-lysine (PLL) and poly-L-omithine are the most 
commonly used cationic polymers for gene delivery. Dif- 
fering in chemical structure only by the length of their side 
chain (4 versus 3 carbons), they are capable of mediating 
gene delivery both in vitro and in vivo (Duguid et al. (1998) 
Biophys. J. 74:2802-2814). In order to form uniform com- 
plexes, these polymers are generally synthesized on a solid 
support using a series of protectingide-protecting synthetic 
steps (e.g. Fmoc chemistry) to obtain mono-disperse pep- 
tides. PLL is typically used at charge ratios (+/-) ranging 
from 3:l to 6:l. The ideal length of the PLL represents a 
balance between two competing effects: effective conden- 
sation and cytotoxicity. Relative to low molecular weight, 
the high molecular weight PLL forms tighter, smaller con- 
densates that are more resistant to the effects of salt con- 
centration and sonication [Adami et al. (1998) J. Pharm. Sci. 
87: 678-683). However, cytotoxicity has been found to be 
inversely related to particle size (Duguid et al. (1998) supra), 
likely due to the high molecular weight PLL. 
Poly(ethy1enimine) (PEI) has been widely used to mediate 
gene delivery due to its high cationic charge density result- 
ing from the protonatable amine on every third carbon. PEI 
can be synthesized by the acid catalyzed ring opening 
polymerization of aziridine as either a linear or a branched 
structure. Similar to the PLL complexes, low molecular 
weight PEI is less cytotoxic than high molecular weight PEI. 
Furthermore, PEIIDNA complexes must also bear a net 
positive charge (6-13: 1 +/-ratio) in order to efficiently trans- 
fect cells (Boussif et al. (1995) Proc. Natl. Acad. Sci. USA 
92:7297-7301; Fischer et al. (1999) Pharm. Res. 
16: 1273-1279, Goula et al. (1998) Gene Ther. 5:712-717). 
The presence of sodium chloride during complexation can 
result in particles with amorphous shapes and diameters 
greater than 1 pm. 
Dendrimers are an attractive architecture for gene transfer 
because their well-defined structure and robust chemistry 
enables the synthesis of many generations of protonatable 
amines. Starbust dendrimers such as polyamidoamine den- 
drimers (PAMAM) are capable of mediating gene delivery 
(Fischer et al. (1999) supra; Bielinska et al. (1997) Biochim. 
Biophys. Acta 1353:180-190; Qin et al. (1998) supra). 
PAMAM can be synthesized from either an ammonia or 
ethylenediamine core by successive addition of methyl 
acrylate and ethylenediamine (Tomalia et al. (1990) Angew 
Chem. Int. Ed. Engl. 29:138-175). The surface charge and 
diameter of the dendrimer is determined by the number of 
synthetic steps (i.e. number of generations). The generation 
of PAMAM used to complex DNA determines particle size 
and transfection efficiency. At charge ratios (+I-) above or 
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equal to one, no free DNA is observed. Higher levels of molecule with the substrate. Alternatively, the solid substrate 
transfection are observed for PAMAWDNA complexes itself may degrade to release the molecule of interest. 
formed from generation 5 and 6 dendrimers than with lower In one particular aspect, the method of the present inven- 
PAMAM generations [Fischer et al. (1999) supra). tion spatially controls gene delivery to cells within pre- 
Cationic polymers can also be used in combination with defined On a substrate. A DNA sequence 
~iposomes, DNA is initially complexed with PLL at low encoding for a specific gene, for example, is localized to a 
charge ratios and cationic lipids are subsequently added to distinct On a (e.g., a glass for 
completely condense the DNA, ~ l ~ ~ ~ ~ ~ ~ i ~ ~ l ~ ,  the PLL con- to cells cultured within that domain. Internalization of the 
densed DNA containing a net positive charge can subse- DNA the a gene 
quently be complexed with an anionic lipid, precondensa- 10 within each domain. Thus, an array of cells is created in 
tion with polylysine has been shown to reduce serum which gene expression varies between domains. 
inhibition and also enhanced the transfection efficiency genes can be used quantify the effectiveness 
(Mtiello et al. (1996), Gene Ther. 3:396-404; Gao and gene genes the quantification 
Huang (1996) Biochemistry 35:1027-1036). the spatial location of protein production and the quantity of 
15 protein produced. A plasmid encoding for green fluorescent 
Control of DNA Delivery to Cell protein (GFP) for example, may be used to follow expres- 
ne nucleic acid may be internalized directly from the sion in the cell population cultured on the surface over time 
surface since each nucleic acid molecule is complexed with Using a fluorescence microsco~e (see the examples below). 
many acessory molecules and only a fraction of them are The quantity of protein production also can be quantified 
tethered. Alternatively, the tethers linking the complex to the 20 Using the reporter gene luciferase, which is assayed with a 
surface may be broken, thus releasing the entire complex as luminometer. 
a soluble factor into the immediate cellular microenviron- Uptake of the complex can be tracked by attaching a label 
ment for internalization. This system also provides the (e.g., a fluorescent tag) to the molecule of interest or to the 
potential to spatially and temporally control gene delivery to tether~ol~linker. The labeledn~~lecule could be followedb~ 
cells on the scaffold, spatial control is obtained through 25 fluorescence microscopy to determine if it has been inter- 
regulating the location where the DNA is tethered to the nalized or acted Upon by the cell. Labeling the tether 
surface. Temporal control is obtained through the number of ~ ~ l ~ l i n k e r  with one fluorescent tag and the molecule of 
tethers used in localizing the DNA complex to the surface. interest with a different tag may be Used to follow the 
Release of the complex into solution or uptake by cells may position and timing of each component separately. 
not occur if few tethers remain; thus, the timing of release 30 The technique of tethering DNA to adhesive surfaces for 
or uptake can be regulated through the number of tethers that d ~ a n c e d  gene transfer has additional applications for in 
must be broken, ~h~ surface density of DNA, the number vivo gene delivery and tissue engineering. Tethering of DNA 
and type of tethers, the properties of the scaffold, and the to the surface of a solid SupPo* (e.g., polymer, glass) 
design of the polylinker are major design criteria that affect increases cellular Uptake by placing the DNA directly at the 
release and uptake. 35 cell surface, thus overcoming many mass transfer limitations 
The number of tethers can be used to regulate how tightly associated with gene transfer. Cells will adhere to the 
a molecule of interest is associated with the solid support, material surface to which the DNA is tethered. Additionally, 
Fewer tethers can allow for a quicker release or uptake of the the tethering provides for a technique to which 
molecule of interest, whereas more tethers can delay the access to the DNA and for regu1ated 
release or increase uptake time. 40 gene delivery. 
In the present invention, controlled gene delivery and 
The tethers or the bifunctional cross-linkers of the present expression is achieved by sequestering DNA to specific 
invention can either be transient, that is a tether that they can locations, using techniques that still allow for internalization 
be designed to break or be broken after a certain desired time and expression, The strategy, shown in FIG, combines the 
frame, Or can be designed to be such 45 techniques of protein DNA packaging, and sus- 
as a protein which is proteolytic enzymes, Or tained release, In one example of the method of the inven- 
alternatively, the tether can be relatively stable such a plastic tion, plasmid DNA is initially complexed with multiple 
or nylon. types of cationic peptides in a process known as DNA 
In the case of a transient tether, the freeing of the molecule condensation~a process designed to enhance cellular 
of interest can be effected by hydrolysis, in which the tether 50 uptake and nuclear trafficking, Hundreds of cationic pep- 
degrades slowly with time in the Presence of water. In tides bind to each plasmid. A fraction of these peptides are 
another embodiment, the tether is sensitive to an outside subsequently tethered to a support substrate using tech- 
stimulus such as light, free radicals, radiation, etc., thereby niques established for controlled protein delivery. A support 
being degraded by the stimulus and releasing the n~~ lecu l e  substrate can be glass or plastic, but for in vivo gene delivery 
of interest. One example of a transient cross-linker, is a 55 and tissue engineering is more preferably a biocompatible 
protein that can be enzymatically cleaved causing the mol- solid substrate such as collagen or alginate, or a polyethyl- 
ecule of interest to be released. The enzymes catalyzing the ene glycol (PEG) based hydrogel. The tethering results in 
bond-breaking reaction may be secreted by the cells or DNA being localized ionically at the surface of the support 
alternatively may be present in the extracellular space. substrate by the covalently bound peptides. The peptides 
The case of a permanent tether or cross-linker, the mol- 60 function to package the DNA for efficient transfection while 
ecule of interest would not be released as a soluble factor the substrate surface localization maintains the DNA in the 
into the media, but would have to interact with the cell cell microenvironment for extended times, thus providing 
directly from the substrate surface. If the molecule of prolonged opportunities for internalization. The optimal 
interest needs to be internalized, the cell would have to pull number of tethers represents a balance between competing 
the molecule away from the components that link it to the 65 effects. If no tethers are present, the DNA is free in solution 
surface; thus, the strength of interaction of the molecule with to be internalized, but spatial control cannot be achieved. If 
the cell would need to be greater than the interaction of the every peptide is a tether, internalization may not be possible 
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because of the strong ionic interaction between the DNA and proliferation stage to a final mineralization stage. By means 
the peptide. Therefore, the amount of tethering of the DNA of controlled gene delivery, tissues could be engineered by 
to the support substrate will vary with application. This can incorporation of appropriate signals into a support scaffold. 
be achieved forming DNA that are tethered A, application of spatially controlled gene delivery is 
the "lid with varying number of tethers. For nerve regeneration, Neurite extension is guided by gradients 
can be seeded Onto the ''lid and in various factors (e.g., NGF, netrins). Spatially controlled 
examined for their ability to internalize and express a given 
expression of these genes can be used to create these 
gene. The optimal number of tethers to employ is therefore 
readily determined by testing this for any concentration gradients. The number and orientation of 
desired application. lo  neurites in response to the chemical gradients are quantified 
Another consideration is that the number of tethers can be measures of the 
designed to decrease with time, either through the action of An application of temporally controlled gene delivery is 
proteases or through a degradable linker. The appropriate bone development, which has been characterized by three 
tethering serves to maintain the DNA at the surface for stages. The expression of stage-specific genes is examined 
internalization either by receptor-mediated endocytosis 15 for effects on mineralized tissue formation. A gene encoding 
which pulls the DNA from its ionic interaction with the for a growth factor (e.g., TGFfl) is delivered early to increase 
tether or by degradation of the tethers which i-ekases the cell density while a second gene (e.g., osteocalcin) is deliv- 
DNA complex into solution in the cell microenvironment. ered later to enhance mineralization, cell density, mineral- 
Cell Culture ization, and bone-specific gene expression are used as mea- 
cells seeded onto the solid substrate can be cultured in 20 sures of tissue formation. These applications demonstrate 
vitro to ultimately produce tissues or portions of tissues for the potential of this approach, which has additional appli- 
tissue transplantation. The culturing of cells on the solid cation to numerous cell systems. 
substrate can be performed by placing the cell/solid sub- The present invention also provides methods of determin- 
strate in a medium that contains the necessary factors for cell 25 ing the effect of gene expression on cell function, A par- 
survival. The cell/solid substrate is subsequently placed in a ticular method ofthis type comprises adding a ce l~  to a well 
37" C. incubator, that may have controlled humidity and of the ,icrotiter plate comprising multiple wells in which 
Oxygen is performed the wells contain condensed nucleic acids encoding a pro- 
in a bioreactor which acts to regu1ate the temperature, tein, The function of the cell is then monitored, The effect of 
Oxygen and nutrient for 'ptimal growth On the 30 the expression of the protein encoded by the condensed 
solid substrate. 
nucleic acid on cell function is then determined. In another 
The present invention also provides methods for prepar- 
ing tissue ex viva, One such embodiment comprises seeding the are then for a desired effect, for 
a cell on a solid substrate of the present invention and decreased resistance a 
culturing the cell in a medium that contains the necessary The DNA encoding the protein causing the 
factors for survival, a particular embodiment the cell is a 35 response can be identified based on its location in the array. 
native progenitor cell. In another embodiment the cell is a Similar approaches could be used using arrays of antisense 
transplanted stem cell. In a particular embodiment the cell is oligonucleotides; for example, by preparing DNA~ol~linker 
an osteoblast. In yet another embodiment, the cell is a complexes with different DNAs of u ~ ~ h o w n  fu ction, teth- 
hematopoietic stem cell. In still another embodiment, the ering the complexes to a solid support in a microarray 
cell is a hepatocyte. In yet another embodiment, the cell is 40 format, and adding cells to in an array, cells plated on the 
an embryonic stem cell. In a particular embodiment the array would then be assayed for their ability to respond to 
condensed nucleic acid of the solid substrate had been certain stimuli. In this manner, one could identify important 
delivered in a spatially controlled pattern to the solid sub- targets for pharmaceutical intervention (e.g., through the use 
strate. In a preferred embodiment, the condensed nucleic 45 Of compositions comprised of antisense oli- 
acid comprised by the solid substrate encodes a protein that gonucleotides or other molecules inhibiting the expression 
directs tissue formation. In a particular embodiment of this activity ofthe target), l-he invention also provides a 
type, the protein is a growth factor. In an alternative embodi- tool for research; e,g,, by selectively inhibiting the expres- 
ment the protein is a cytokine. In still another embodiment, ,ion of different proteins involved in intracellular signaling, 
the condensed nucleic acid comprised by the solid substrate 50 One could identify the signaling pathways involved in a 
encodes a transcription factor. In Yet another embodiment, cellular response to a stimulus. It is anticipated that the cell 
the condensed nucleic acid comprised by the solid substrate function assays ofthe present invention can be adapted into 
encodes at least two of the following: a growth factor, a a format suitable for high-throughput screening, 
transcription factor and a cytokine. 
The present invention further provides methods for regen- 
Applications 55 erating tissue at the site of a wound. In one embodiment, the 
Tissue engineering aims to create functional tissue method comprises contacting a solid substrate of present 
replacements for patients suffering from organ loss or tissue invention with a cell at the site of the wound. In a preferred 
failure. To achieve this objective, these tissues will develop embodiment of this type, the condensed nucleic acid com- 
from native progenitor cells or transplanted stem cells on a prised by the solid substrate encodes a protein that directs 
synthetic scaffold that mimics the natural environment. 60 tissue formation. In a particular embodiment of this type, the 
Controlled gene delivery allows spatial variations in gene protein is a growth factor. In an alternative embodiment the 
expression enabling the organization of multiple cell types protein is a cytokine. In still another embodiment, the 
within a tissue (e.g., nerve cells surrounded by supporting condensed nucleic acid comprised by the solid substrate 
Schwann cells) or provide a directional signal (e.g., neurite encodes a transcription factor. In yet another embodiment, 
extension). Temporal patterns regulate the switching of cell 65 the condensed nucleic acid comprised by the solid substrate 
function from an immature to a mature stage. For example, encodes at least two of the following: a growth factor, a 
during bone development, osteoblasts switch from an initial transcription factor and a cytokine. 
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Creating Spatial Patterns for Expression of the Nucleic Acid In a particular embodiment of the present invention a 
Spatial patterning of genes onto surfaces can be per- Support surface is employed that has the ability to gel upon 
formed using a multitude of methodologies. For example, an implantation into the body (Elisseeff et al. (1999) Plast 
arrayer may be used to place a specified volume onto a Reconstr Surg, 104:1014-1022). Implantation of the mate- 
specific spot on the solid substrate, An arrayer is currently 5 rial results in gelling and filling of the desired space. Cells 
being employed to spatially oligonucleotides for from the surrounding tissue would then interact with the 
material and would be presented with the molecule of 
gene chips. Alternatively, microfluidics technology can be 
interest to direct its action, such as for regeneration of a 
used to specifically deposit a liquid containing DNA onto a tissue (i,e,, tissue engineering), of an immune 
'pecific region of the "lid substrate. In yet another embodi- 10 response (e,g,, cancer therapies), secretion of a therapeutic 
ment, the solid substrate can be chemically modified using molecule (i,e,, drug delivery), or any other desired cell 
any of a variety of photolithography techniques. function. 
Specific Embodiments Example 1 below describes experiments examining teth- 
ering complexed polylysine (PLL)IDNA on glass slides, 
Thus the present invention combines DNA condensation 15 surface densities achieved. and use in cell transfection, 
with polymeric delivery to tether DNA complexes to a Example 2 describes the synthesis of biotinylated PLL 
surface (FIG. 11, to which cell adhesion can be controlled. and complexation with DNA. Polylysine was covalently 
DNA is ionically complexed with a cationic peptide to modified with biotin residues either through an N-terminal 
stabilize against degradation and to enhance uptake. A cysteine side chain (K,,) or through an (K,,,), HPLC 
fraction of the cationic peptides that package the DNA are 20 analysis of the initial peptide (K,,) and the peptide reaction 
subsequently tethered to the surface of a support substrate, mixture (K,,-B) demonstrated that the reaction proceeded to 
thus maintaining the DNA at the surface through an ionic completion (FIG, 71, as evidenced by the increase in 
interaction. The linkages can be designed to be temporary, molecular weight in the reaction mixture and the absence of 
either through enzymatic degradation of the bifunctional the lower molecular weight K,, peak, M~~~ spectrometry 
crosslinker or through a reversible tether. The mechanism of 25 (FIG, 8) suggests that the approach for modifying the 
uptake may be direct internalization of the plasmid from the peptide K,, in the attachent ofa single biotin group, 
surface (e.g., few tethers Per complex) or may follow A good correspondence was found between the theoretically 
complete degradation of the tethers or bifunctional expected molecular weight for K,, modified with a single 
crosslinkers, which would release the plasmid directly into biotin (31 58 D ~ ) ,  and the experimentally obtained molecular 
the cell microenvironment. Controlled delivery and uptake 30 weight (3157,6620.77 Da). Alternatively, the chemistry 
Occurs through variations in the type and number of tethers employed for modification of K,,, allows for multiple biotin 
per plasmid. residues to be attached per PLL. The K,,,-B synthesis 
One important aspect of the present invention is based resulted in a 3.1:l molar ratio of biotin to K,,, by using a 
upon the efficient and spatially controlled delivery of nucleic 10: 1 molar ratio of biotinylation reagent to K,,, in the 
acids to cells cultured on a slide. By themselves, plasmid 35 reaction mixture. 
DNA and oligonucleotide are not efficiently internalized by As described in Example 3, the synthesized biotinylated 
cells and delivery cannot be spatially controlled; however, and non-biotinylated peptides were subsequently analyzed 
packaging the nucleic acids into complexes can overcome for their ability to complex with DNA using gel electro- 
these limitations. Complexation with a cationic polymer phoresis. The non-biotinylated peptides (K,,, K,,,) com- 
(e.g., poly-L-lysine, PLL)-a process termed condensa- 40 pletely eliminate the electrophoretic mobility at charge 
tion-produces a particle with size ranging from 46100  ratios of 3.1 and 1.2 respectively (results not shown). 
nm, a size readily internalized by cells (Mahato et al. (1999) However, the presence of the biotin group on the peptide 
Adv. Genet. 41:95-156). These condensates can contain affected the charge ratio at which the mobility is eliminated, 
fusogenic peptides or nuclear localization signals or may be which is 4.6 and 4.9 for K,,-B and K,,,-B respectively. 
functionalized with receptor ligands to enhance targeting, 45 Mixtures of K,,,-B with K,, were also examined by gel 
internalization, and intracellular trafficking of the complex electrophoresis for DNA complexation at a charge ratio of 
(Cristiano and Curie1 (1996) Cancer Gene Ther. 3:49-57). 5.5:l. The inhibition of mobility was observed for all 
The desired spatial control over delivery is obtained by combinations of the two peptides. The results illustrate that 
combining DNA complexation with spotting technology and the biotinylated peptides, non-biotinylated peptides, and 
localized drug delivery. Following condensation, plasmids 50 mixtures of biotinylated and non-biotinylatd peptides are 
and oligonucleotides are spotted into domains (106500 pm) capable of electrostatically neutralizing plasmid DNA and 
on a slide using, for example, the Aemetrix Pin and Ring. eliminating its electrophoretic mobility. 
The nucleic acid condensate is retained within the domain The availability of the biotin groups on the PLL for 
by subsequent tethering of the complex to the surface using tethering to a surface was determined using the affinity of 
a bifunctional cross-linker (FIG. 2). One functional group on 55 biotin for neutravidin (non-glycosylated avidin). Surface- 
the cross-linker is coupled to a fraction of the cationic associated DNA was visualized for DNA complexed with 
polymers that condense the nucleic acid. The remaining K,,,-B. Fluorescence images taken after the initial incuba- 
functional group on the bifunctional cross-linker reacts with tion on the surface and before the wash demonstrates the 
functional groups on the surface, thus tethering the complex presence of complexes across the entire surface (results not 
to the surface. The nucleic acid is maintained ionically at the 60 shown). Thorough washing of the surfaces resulted in a 
surface for direct delivery into the cell microenvironment. reduction of the quantity of surface-associated DNA. All 
Sustained plasmid delivery from surfaces that support cell subsequent studies used surfaces that were thoroughly 
adhesion has demonstrated an increased uptake and expres- washed to ensure binding specificity of the complexes. 
sion (Shea et al. (1999) supra), likely due to high concen- The quantity of surface associated DNA was subsequently 
trations at the cell surface (Luo et al. (2000) supra) and 65 measured as a function of the PLL peptides and the number 
prolonged exposure to the plasmid, which provides multiple of biotin groups per complex. Non-biotinylated peptides 
opportunities for internalization. used for DNA condensation resulted in low surface densities 
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( ~ 0 . 1  pg DNA/c~')  due to non-specific adsorption. The use The expression levels of protein at 96 hrs by cells cultured 
of biotinylated peptides for DNA complexation increased on DNA-modified surfaces increased relative to the that 
the surface density of DNA relative to the condition of no observed at 48 hours and, for all biotinylated DNA com- 
biotin groups (pe0.05), suggesting that biotin groups are plexes, was greater than that obtained by bulk delivery. 
available on the DNA complexes for interactions with the 5 Maximal expression levels by HEK293T cells was obtained 
surface-associated neutravidin. The maximal amount of sur- for the complexes containing 28 biotin groups and was 
face-associated DNA was observed for DNA complexes statistically significant from all other conditions tested 
formed solely with biotinylated peptides (pe0.001), with (pe0.05) (FIG. 13). The expression level decreased as the 
densities of 2.9 and 4.3 pg DNA/cm2 obtained for K,,,-B average number of biotin groups on the complex increased 
and K,,-B respectively (FIGS. 9-10). Complexes formed l o  (pe0.05). The complexes formed with K,,,-B (1705 biotin 
from either K,,,-B or K,,-B were calculated to have an groups) had the lowest transfection level of the surface 
average number of biotin groups equal to 1705 and 4342 associated delivery; however, the expression level was sig- 
respectively. These surface densities correspond to a tether- nificantly greater than the bulk control (pe0.01). The expres- 
ing efficiency (mass DNA on surfacelmass DNA added) of sion levels for the NIHl3T3 cells were less dependent on the 
24% (K,,,) and 35% (K,,). For the K,,,-B and K,,-B, 1s number of biotin groups, yet the decreasing expression 
decreasing the amount of DNA incubated on the surface was levels for increasing numbers of biotin groups was again 
found to decrease the amount of surface-associated DNA observed (FIG. 14). For all conditions tested with surface 
(data not shown). The quantity of surface-associated DNA associated delivery of DNA complexes tethered to the 
was also found to decrease as the number of biotin groups surface with biotin groups, an increased level of transfection 
in the DNMPLL complex decreased. The molecular weight 20 was observed relative to the delivery of non-biotinylated 
of polylysine, both biotinylated and non-biotinylated also DNA complexes and the bulk delivery of DNA complexes 
affected the quantity of surface-associated DNA. For the (pe0.01). 
biotinylated peptide K,,,-B, fewer numbers of biotin groups 
were required to obtain an equivalent amount of surface EXAMPLES 
associated DNA as for the peptide K,,-B. However, the use 25 
of the non-biotinylated peptide K,, for complexation Example 1 
resulted in increased DNA surface densities relative to the 
use of K,,,. Use of Tethered PLLIDNA Complexes 
Culture of HEK293T and NIHl3T3 cells on the DNA 
modified surfaces led to cellular transfection at 48 hours, 30 Experiment 1. Plasmid DNA encoding either green fluo- 
with levels of protein production equal to or greater than that rescent protein (GFP) or luciferase was complexed with 
obtained by bulk delivery. The transfection experiments modified poly-L-lysine (PLL) at a ratio of 3.1. PLL was 
(Example 4) used mixtures of K,,,-B and K,, for DNA modified by PLL reaction with the bifunctional cross-linker 
complexation because this combination had an increased sulfosuccinimidyl 6-[3'-(2-pyridy1dithio)-propionamido] 
amount of surface associated DNA relative to the other 35 hexanoate (Sulfo-LC-SPDP, Pierce) prior to DNA complex- 
peptide mixtures, particularly when the complexes had few ation at a 1: 1 molar ratio. The PLLIDNA complexes were 
numbers of biotin groups. Quantification of protein expres- subsequently incubated with glass slides that were modified 
sion levels for HEK 293T demonstrated that complexes with with (3-mercaptopropy1)-trimethoxysilane (MPTS, Sigma) 
28 and 426 biotin groups produced the maximal transfection to create pendant thiol groups. Following coupling of PLLI 
(FIG. l l ) ,  which was statistically greater (pe0.05) than other 40 DNA complexes to the slide, the surfaces were extensively 
conditions with greater numbers of biotin groups. Expres- washed and treated with trypsin to degrade the PLL and 
sion levels obtained for surface-associated complexes with release the DNA into solution. The surface density of DNA 
1705 and 853 biotin groups were not significantly different was determined to be 3.920.78 pg/cm2. Control slides incu- 
from the control conditions, which consisted of bulk deliv- bated with PLLIDNA complexes without the sulfo-LC- 
ery of DNA complexes formed from either K,,, or K,,. For 45 SPDP tether had a surface density of 0.3+0.1 pglcm2 (FIG. 
bulk delivery, the amount of DNA added in complexes with 3). 
K,,, or K,, corresponded to the surface quantities of DNA Experiment 2. Glass surfaces were prepared with pendant 
for K,,,-B (1705 biotin groups) and K,,,-BIK,, (28 biotin disulfide groups by initially coupling MPTS to create pen- 
groups), respectively. These conditions were chosen as the dant thiol groups. The thiol groups were then reacted with 
control conditions to represent the limiting cases of surface 50 dipyridyldisulfide to form pendant disulfide groups on the 
associated delivery regarding DNA quantities (0.7 pg and surface. Plasmid DNA encoding GFP was mixed for 30 
0.1 6 pg) and PLL composition (K,,,, K,,). For the NIHl3T3 minutes with PLL at a charge ratio of 1: 1 (positive to 
cells (FIG. 12), expression levels obtained by surface asso- negative). The polylysine chains in the PLLIDNA com- 
ciated complexes with 28, 426, and 853 biotin was signifi- plexes was covalently coupled to cysteine (which had a 
cantly greater than that obtained with complexes containing 55 protected amino group) using EDC and Sulfo-NHS. The 
1705 biotin residues (pe0.05). No significant difference PLLIDNA complex was subsequently tethered to the glass 
between complexes with 28 biotin groups and its bulk slide through the thiol group on the attached cysteine. The 
control (p>0.05) and 1705 biotin groups and its bulk control glass slides were washed to remove non-specifically bound 
(p>0.05) were found. The distribution of transfected cells complexes. To verify attachment of the PLLIDNA com- 
throughout the cell population also differed between the 60 plexes, the slides were then treated with trypsin to degrade 
delivery mechanisms. For bulk delivery, transfected cells the PLL and release the DNA into solution. This quantity of 
were seen throughout the cell population (not shown); DNA in solution was measured using the Hoechst 33258 
however, surface-mediated delivery resulted in cells that fluorometric dye. The amount of DNA released into solution 
were transfected in clusters. Additionally, the location of was equal to 17.8+3.51 pg, which corresponds to a surface 
transfected cells on the surface was consistent with the 65 density of 3.9320.78 (FIG. 4). The efficiency of incorpora- 
location of surface-associated DNA seen with the fluores- tion was determined to be 13.8+2.7%. Control slides in 
cently-tagged plasmid. which cysteine was not complexed to DNA released 
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0.63+0.18 pg, which corresponds to a surface density of mine if the reaction had gone to completion. The starting 
0.28+0.08 pg/cm2. The amount of DNAtethered to the slides peptide solution and the reaction mixture were resolved by 
was consistent with the amounts typically used in transfec- injecting 20 pg through a C18 RP-HPLC column eluted with 
tions. The integrity of the released DNA was subsequently water (0.1% trifluoroacetic acid (TFA)) and a acetonitrile 
analyzed by gel electrophoresis and found to be intact. 5 gradient (0.1% TFA, 0 to 95% over 50 minutes at 60' C.) 
NIH3T3 cells were plated into the well of the 96 well dish while detecting the absorbance at 260 nm. For purification, 
containing the tethered DNA prepared as described above. sephadex (G15) was equilibrated in deionized water for 30 
Cells were cultured at 37' C. At various times, the cells were minutes prior to packing in a glass column (2 cm diameterx 
examined using a fluorescence microscope for the expres- 12 cm height). The reaction mixture was passed though the 
sion of GFP. Transfected cells were observed within the l o  column using deionized water. Twenty fractions were col- 
wells of the dish. lected and the presence of the tryptophan side chain was 
Experiment 3. Tethered DNA complexes were attached to examined by measuring the absorbance at 260 nm (Beckman 
96 well polystyrene microtiter plates with a streptavidin Instruments Inc., Fullerton, Calif.). The fractions with the 
coating as follows: PLL was reacted with the bifunctional greatest absorbance at 260 nm were lyophilized (Labconco 
cross-linker sulfo-NHS-LC-Biotin (Pierce) prior to DNA 1s Corp., Kansas City, Mo.) and analyzed by mass spectrom- 
complexing at a 1: 1 or 10: 1 molar ratio (Biotin:PLL), etry. The purified biotinylated peptide (K,,-B) was stored as 
generating biotinylated PLL. To form the complexes, bioti- a powder at -20' C. 
nylated PLL was mixed with DNA at a charge ratio of 3: 1 Peptide K,,, was biotinylated using succinimide ester 
and allowed to self-assemble for 30 minutes. The complexes (NHS)/amine chemistry. K,,, (10 mg) was dissolved in 1 
are formed such that the biotin groups are available for 20 mL of phosphate buffered saline (PBS, pH=7) and EZ-link- 
specific coupling to a surface through a streptavidin-biotin Sulfo-NHS-LC-Biotin (2.8 mg) was added directly to the 
interaction. These complexes were subsequently incubated solution, mixed gently and incubated for 2 hours at 4' C. The 
(1-2 hours) in streptavidin modified 96-well plates. Follow- reaction mixture was purified using dialysis cassettes 
ing coupling of PLLIDNA complexes to the wells, the immersed in deionized water. The dialyzed product was 
surfaces were extensively washed with TNBS buffer and 25 further purified using a monomeric avidin column to sepa- 
treated with trypsin to degrade the PLL and release the DNA rate the biotinylated components from non-biotinylated spe- 
into solution. The number of biotin groups available for cies. The biotinylated product was eluted with 10 ml of a 10 
coupling controlled the surface density of DNA. Experi- mM biotin solution and dialyzed to remove the unconju- 
ments using 200, 100, and 50 moles biotinylated PLLImoles gated biotin. The purified biotinylated peptide (K,,,-B) was 
DNA and the 1:l molar ratio (Biotin:PLL) PLL, yielded the 30 then lyophilized and stored as a powder at -20' C. The 
following surface densities: 1.16+0.01 pg/cm2, 2.54+0.05 degree of biotinylation of K,,,-B was determined by quan- 
pg/cm2, 2.17+0.08 pg/cm2 respectively. Similar experiments tifying the mole ratio of biotin to K,,, using 2[4'-hydroxya- 
with the 10:l molar ratio yielded surface densities of zobenzenel-benzoic acid (HABA). The absorbance at 500 
2.14+0.16 pg/cm2, 0.32+0.05 pg/cm2, and 0.41+0.06 nm of a HABMavidin solution in PBS was recorded before 
pg/cm2. Control slides incubated with PLLIDNA complexes 35 and after the addition of the K,,,-B and used to calculate the 




40 Complex Formation and Surface Tethering 
Synthesis of Biotinylated Poly-Lysine 
The ability of the biotinylated and non-biotinylated polyl- 
Plasmid DNA encoding for 0-galactosidase (pNGVL1-0- ysine (K,,,, K,,,-B, K,,, K,,-B) synthesized as described 
gal) was purified from bacteria culture using Qiagen (Santa above, to condense DNA was assessed by gel electrophore- 
Clara, Calif.) reagents and stored in Tris-EDTA buffer solu- 45 sis. Biotinylated and non-biotinylated peptides were mixed 
tion (10 mM Tris, 1 mM EDTA, pH=7.4). Fluorescein and added in a stepwise manner (1 pL of 1 mg/mL) to a DNA 
tagged 0-galactosidase vector (Fl-0-gal) was purchased solution (200 pL of pg/mL). After each addition step, the 
from Gene Therapy Systems (San Diego, Calif.). Two polyl- solution was vortexed for 4 seconds, incubated for 10 min 
ysine (PLL) peptides were used for DNA complexation: and a sample (10 pL) removed. Upon complete addition of 
Cys-Trp-Lyslg (K,,, BioPeptide, San Diego, Calif.) and 50 peptide, trypsin was added to digest the polylysine. Gel 
LyslSo (K,,,, average molecular weight of 20,000, Sigma, St electrophoresis was performed to assess the extent of com- 
Louis, Mo.). Avidin and biotin reagents for peptide modifi- plex formation for the samples and the trypsin-digested 
cation and surface tethering were purchased from Pierce DNA solution. 
(Rockford, Ill.). All other reagents were obtained from DNMPLL complexes were incubated on surfaces to spe- 
Fisher Scientific (Fairlawn, N.J.) unless otherwise noted. 55 cifically tether the complexes through the biotin-neutravidin 
Peptide K,, was modified with a biotin group through the binding. DNA (90 pL of 44.4 pg/mL) was complexed at a 
terminal cysteine residue by reaction of the sulfhydryl group charge ratio (+I-) of 5.5:l with the four peptides (K,,,, 
with the iodoacetyl group of the biotinylation reagent, K,,,-B, K,,, or K,,-B) individually or with mixtures of 
EZ-link-PEO-Iodoacetyl-Biotin. K,, (10 mg) was dissolved biotinylated and non-biotinylated peptides. The number of 
in 850 pL of buffer (50 mM Tris, 5 mM EDTA, pH=8.3) that 60 tethers on each complex is varied by mixing biotinylated and 
was previously bubbled with nitrogen gas. The EZ-link- non-biotinylated PLLs prior to complexation with DNA. 
PEO-Iodoacetyl-Biotin (3.8 mg) was also dissolved in 150 Complexes were incubated after mixing for 30 min at room 
pL of buffer (0.1 M Sodium Phosphate, 5 mM EDTA, temperature and then allowed to bind to pre-washed neu- 
pH=6.0). The biotin solution was added dropwise to the travidin coated surfaces for 2 hours. The unbound com- 
peptide solution, mixed gently, covered with aluminum foil 65 plexes were then removed from the wells and washed with 
and incubated for 90 minutes. The starting peptide solution tris-buffered saline (TBS). The surface quantities of DNA 
and the reaction mixture were analyzed by HPLC to deter- were determined by incubating with trypsin (100 pL) at 37' 
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C. for 2 hours to degrade the PLL and release the DNA into were determined at room temperature with a goniometer 
solution. The quantity of DNA was measured with a fluo- (Ram&-Hart), which is equipped with a camera system and 
rometer (Turner Designs TD-360) using the Hoechst dye. DROPimage Standard software. A water droplet was dis- 
Tethered DNA complexes were visualized by fluorescence pensed and angle measurements were recorded as the angle 
microscopy using the F1-0-gal vector before and after wash- 5 between the surface and tangent at the droplet contact with 
ing with TBS. the surface. 
Example 4 Complex Formation and Immobilization 
Addition of cationic polymers or lipids to plasmid DNA 
Cell Culture and Transfection lo  results in self-assembly to form colloidal polyplexes and 
lipoplexes, respectively. The complexing agents used were 
Transfection of cells on the DNA-modified surfaces. 
produced as described above, was examined using a 0-ga- 
lactosidase plasmid and two cell lines (HEK293T and NIHI 
3T3). Polyethyleneimine (PEI, 22 kDa, MBI-Fermentas, 
Hanover, Md., 0.5 pL of 10 pM) was added to DNA- 
modified surfaces and incubated for 5 min. Cells were then 
plated and cultured on the surfaces for 48-96 hours and then 
lysed for assay of 0-galactosidase enzyme activities 
(Promega, Madison, Wis.) and protein levels (BioRad, Her- 
cules, Calif.). Alternatively, cells were stained with X-gal to 
determine the location of transfected cells. HEK293T and 
NIHl3T3 were cultured at 37' C. and 5% CO, in Dulbecco's 
modified eagle medium (DMEM, Life Technologies, Gaith- 
ersburg, Md.) supplemented with 10% heat inactivated FBS 
and 1% penicillidstreptomycin. Control experiments to 
characterize the effectiveness of surface-mediated delivery 
were performed by using bulk delivery of DNA complexed 
with the non-biotinylated K,,, or K,,. For bulk delivery of 
K,,,IDNA complexes, the quantity of DNA delivered was 
determined based on the amount of surface associated DNA 
obtained when DNA was complexed only with K,,,-B. For 
bulk delivery of K, ,/DNA, the quantity of DNA delivered 
the branched cationic polymer p~yethylenimine (PEI) and 
Lipofectamine 2000. Complexes with PEI, termed poly- 
plexes, were formed at the desired NIP (range 5-25), while 
DNA complexed with Lipofectamine 2000, termed 
lipoplexes, were formed at ratios of DNA:lipid (pg:pL, 
range 0.5-5). For polyplexes, polymer solution (60 pL in tris 
buffered saline) is added drop wise to DNA (60 pL), 
vortexed, and incubated for 15 minutes at room temperature. 
For lipoplexes, lipid (50 pL) is added drop wise to DNA, 
mixed by gentle pipetting, and incubated for 20 minutes. 
Lipoplexes were formed in serum free cell growth media. 
Zeta potential and z-average diameter were measured with a 
Zetasizer Nano ZS (Malvern. Worcestershire. UK). Com- , , 
plexes were immobilized by incubation on either untreated 
or serum-coated tissue culture polystyrene. Polystyrene (PS, 
96-well strip plate) was serum-coated (FBS-PS) by incuba- 
tion with heat inactivated fetal bovine serum (200 pL, 10% 
in PBS, pH=7.4) for 2 hours, followed by two wash steps 
with PBS. Complexes were immobilized immediately fol- 
lowing complex formation by incubation of DNAcomplexes 
(100 pL) with the substrate for 1-24 hours, which was 
followed by two wash steps. 
was determined based on the amount of surface-associated Quantification of Immobilized DNA and DNA Release 
DNA obtained when DNA was complexed with a mixture of 35 ~h~ binding and release of DNA from the substrates was 
Ki,o-BIKi9, whichhada predominance K19 over K150-B. monitored using plasmid DNA radiolabeled with 32P dATP. 
For the bulk delivery experiments, HEK293T and NIH3T3 Briefly, a nick translation kit (Amersham Pharmacia Bio- 
cells were plated at one day prior to transfection and cultured tech, Piscataway, N.Y.) was used following the manufactur- 
in complete media. er's protocol with minor modifications (Segura et al. 2003). 
40 Following immobilization and washing, complex surface 
Example 5 density was determined by immersing individual wells in 
scintillation cocktail (5 mL, ScintiVerse 11) for measurement 
Gene Delivery Through Adsorbed DNA Complexes with a scintillation counter. The counts were correlated to 
DNA mass using a standard curve. To determine the release 
Materials and Methods 45 profile, substrates with immobilized DNA were incubated 
with PBS or conditioned media (200 pL) at 37' C. in a 
Materials humid chamber. Conditioned media was collected from 
Plasmid DNA encoding for luciferase or enhanced green cultures (at least 24 hours) of NIHl3T3 cells. At predeter- 
fluorescent protein (GFP) with a CMV promoter was puri- mined time points, half of the solution (100 pL) was 
fied from bacteria culture using Qiagen (Santa Clara, Calif.) 50 removed and replaced with fresh solution. The activity of the 
reagents and stored in Tris-EDTA buffer (10 mM Tris, 1 mM collected sample was measured in a scintillation counter. At 
EDTA, pH=7.4). Branched polyethylenimine (PEI, 25 kDa) the final time point, the counts remaining on the substrate 
was purchased from Aldrich (St. Louis, Mo.). Lipofectamine were also determined. The percentage of DNA released was 
2000 was purchased from Invitrogen (Gaithersburg, Md.). calculated as the ratio of the cumulative counts released 
All other reagents were obtained from Fisher Scientific 55 through a given time divided by the total counts initially on 
(Fairlawn, N.J.) unless otherwise noted. the substrate. 
Surface Modification Cell Culture and Transfection 
Tissue culture polystyrene (PS) was used as provided or Transfection studies were performed with NIHl3T3 
after modification with fetal bovine serum (FBS-PS). Modi- 60 (ATCC) cells cultured at 37' C. and 5% CO, in DMEM 
fication was characterized using X-ray Photoelectron Spec- supplemented with 5% sodium pyruvate, 1.5 g NaHC03 and 
troscopy (XPS), which uses x-rays to eject electrons, which 10% FBS. Cells were seeded at a density of 5,000 cells per 
can be measured and correlated to chemical states. XPS well in 96-well plates. For substrate-mediated delivery, cells 
spectra were recorded using an Omicron ESCAProbe system were seeded immediately following complex immobiliza- 
with an AlIMf anode X-ray source. The wettability of the 65 tion and wash. Control studies were performed with bolus 
surfaces was determined through measurement of the con- delivery to cells plated in a 48-well dish at a density of 
tact angle of water droplets on the surface. Contact angles 15,000 cellslwell and allowed to incubate overnight. The 
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quantity of DNA delivered as a bolus was equivalent to the (Table 1). The FBS treated surfaces had a low contact angle 
amount of DNA immobilized to the substrate, with normal- (~15') relative to the unmodified PS surface (48"). 
ization to the larger well. Complexes were formed as 
Complex Immobilization and Stability 
described above, but with a final volume of 30 pL. Trans- The amount of DNA immobilized to the surfaces 
fection was analyzed following a 48-hour culture. 5 .  
increased with time of incubation on the surface and was 
Transfection was characterized through the extent of dependent upon the chemical properties of the surface and 
transgene expression (luciferase) and the number of trans- DNA complex, Incubation of DNA complexes with the 
fected (GFP). The extent of transgene was substrate for 24 hours resulted in surface densities of at least 
quantified by measuring the luciferase activity using the pg1cm2, which corresponds to immobilization of more 
Luciferase 'ystem (Promega, Wis.). lo than 60% of the DNA (FIG, 17A). Polyplex deposition on 
were lysed and assayed for enzymatic activity after 48 hours. pS and FBS-PS occurred at similar rates during the first 
The luminometer was set for a second and an hours of incubation; however, deposition onto FBS-PS 
integration of the signal for 10 seconds. Transfected cells slowed relative to PS during the final 16 hours, resulting in 
were visualized and manually counted using a GFP plasmid surface densities of 4,1 pglcm2 and 5,3 pglcm2, respec- 
and e~ifluOrescence (Leica, Bannockbum, Ill.) l5 tively, Lipoplex binding to the substrate was not substan- 
with a FITC and with a digita1 camera. The tially affected by the surface properties during the 24-hour 
percentage of transfected cells was calculated as the ratio of incubation (p>0,05), The retention of complexes on both PS 
the number of transfected cells divided by total cell number, and FBS-PS substrates during incubation in PBS was unaf- 
which was determined by counting of bright fected by surface modification. For polyplexes, incubation in 
images. 20 PBS resulted in 16.5% and 14.3% (p>0.05) release after 8 
Confocal Microscopy days from PS and FBS-PS, respectively (FIG. 17B). For 
DNA complexes were fluorescently labeled with tetram- lipoplexes, incubation in PBS resulted in 10.5% and 21.4% 
ethyl rhodamine (Mirus). Polyplexes were then immobilized b>0.05) after from PS and FBS-PS, respec- 
followed by cell seeding. Cells were cultured for 16 hours, 25 tively 17B). The polyplexes gradually 
and then labeled with the cytoplasmic stain fluorescein lnCreases during the 8 - d a ~  in PBS, whereas 
&acetate (Sigma, St. Louis, Mo.). The distribution of cell l i ~ ~ ~ l e x e s  reach maximal release after 2 to 4 days. Trans- 
and complexes on the substrate was visualized with confocal fection experiments typically involve cell culture for 24-96 
microscopy (Leica). hours, which corresponds to release of 2.75% to 20% of 
30 
immobilized DNA. Increasing the quantity of DNA incu- 
PLG Disk bated with the substrate resulted in increased quantities of 
The biomaterial poly(1actide-co-glycolide) was fabricated immobilized DNA; however, the percentage of DNA immo- 
into a disk using a gas foaming process (Jang and Shea 2003; bilized after a 2-hour incubation is dependent upon surface 
Nof and Shea 2002). After fabrication, disks were coated modification, and complex properties. For polyplexes 
with serum and complexes were incubated with the disk for 35 immobilized to PS substrates, increasing the quantity of 
24 hours as described. After washing, cells were seeded onto DNA incubated on the surface led to a greater percentage 
the disk. Transgene expression was determined using the immobilized for all NIP ratios (FIG. 18A). Furthermore, 
luciferase assay as previously described. Transfected cells increasing the NIP ratio resulted in decreasing quantities of 
were visualized by delivering a plasmid encoding for immobilized DNA. Conversely, polyplexes immobilized to 
nuclear targeted 0-galactosidase and staining with X-gal 40 FBS-PS substrates exhibited no dependence on DNA quan- 
following culture (Shea et al. 1999). titles or NIP ratio (p>0.05). Lipoplex binding to PS sub- 
strates exhibited a dependence on DNA quantities, with 
Results lower quantities binding more effectively than higher quan- 
Complex Formation and Surface Modification tities, and the concentration dependence was significant for 
The z-average diameter and zeta potential of DNA 45 FBS-PS at the lower lipid content. For both PS and FBS-PS, 
plexes, which may impact substrate immobilization and the lipid content of the complexes did not affect the per- 
transfection, were measured and are consistent with pub- centage bound t' the substrate. 
lished reports. The zaverage diameter (dz) of the polyplexes Cellular Transfection 
decreased with increasing amounts of cationic polymer in Cells cultured on substrates with immobilized polyplexes 
the complex, with mean diameters ranging from 1062 nm to 50 and lipoplexes were transfected and the extent of transgene 
121 nm for NIP ratios of 5 and 25, respectively (FIG. 15A). expression depended upon substrate modification, and com- 
Increasing the amount of cationic polymer led to increases plex formulation. Polyplexes and lipoplexes immobilized to 
in the zeta potential of ~ o l ~ ~ l e x e s ,  which ranged from FBS-PS substrates yielded equal or greater transgene 
-14.33 mVt0 a maximum of 21.21 mV at an NIP of 10 (FIG. expression than delivery from PS. For polyplexes immobi- 
15B). NIP ratios greater than 10 did not significantly affect 55 lized at low densities, 
the zeta potential (~>0.05). For l i ~o~ l exes ,  the mean dz FBS-PS substrates yielded 17-fold greater transgene 
ranged from 6032104 nm to 10892340 nm for increasing expression than PS at an NIP of 25, and similar levels for 
amounts of lipid (FIG. 15C). For DNA:lipid ratios greater N/p equal to 10 (FIG, 1 9 ~ ) .  For higher densities of imo- 
than 1:2, increasing the amount of lipid had no significant bilized polyplexes, transgene expression on FBS-PS was 
effect on the zeta potential @>0.05), which averaged -50 60 increased 194-fold and 1638-fold compared to PS surfaces 
mV (FIG. 15D). for NIP equal to 10 and 25, respectively (FIG. 19B). Poly- 
The altered surface chemistry induced by serum coating plex delivery from FBS-PS surfaces enhanced expression 20 
was confirmed with X-ray photon spectroscopy (XPS) and to 49-fold relative to equivalent doses delivered in bolus, 
contact angle measurements. The XPS spectrum indicates with the exception that the highest dose and NIP ratio 
that nitrogen groups are present on FBS-PS, and not on PS 65 providing similar expression levels. 
(FIG. 16). Serum coating also increased the wettability of Lipoplex delivery from PS and serum-modified PS 
the surfaces as determined by contact angle measurements yielded equal levels of luciferase activity under similar 
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dosage and complex conditions. At low dose conditions, FBS-PS. Lower doses of complexes delivered as a bolus 
increasing the lipid content of the complexes led to a 6.5 fold resulted in insignificant luciferase activity (data not shown). 
enhancement in luciferase activity (FIG. 19C), which was Consistent with the NIHl3T3 culture, lipoplex delivery by 
not ~bserved at the higher dose (FIG. 19D). For lipoplexes substrate immobilization resulted in similar expression lev- 
with the lowest lipid content and at the highest dose, an 5 els independent of surface modification (FBS-ps, ps) and 
la-fold ahancement in activity was ob~erved from serum- the lipid content. Additionally, transgene expression for 
surfaces when Other- polyplexes and lipoplexes were similar; however, the per- 
wise, transgene expression was similar between substrate- centage of transfected cells using lipoplexes was approxi- 
mediated and bolus delivery. mately 26%, whereas polyplex immobilization resulted in 
The similar levels of transgene expression obtained by l o  less than 5% of the cells transfected. 
lipoplex delivery from both PS and FBS-PS substrates were 
further examined by quantifying the percentage of trans- ~ ~ ~ ~ ~ f ~ ~ t i ~ ~  from a ~ i ~ ~ ~ t ~ ~ i ~ l  scaffold 
fected The percentage of transfected was Substrate-mediated gene delivery can be applied to sub- 
increased nearly 2-fold on FBS-PS relative to PS, indepen- 
strates other than PS, which may expand the applications of 
dent of quantity immobilized and the lipoplex composition 1s 
(FIG, 20A, B; p<0,05), Substrate-mediated delivery from this mechanism. Pol~(lactide-co-gl~colide) (PLG) 
FBS-PS resulted in similar or greater percentages of trans- disks were incubated with P ~ ~ Y P ~ ~ ~ ~ ~ ,  in the 
fected cells relative to bolus delivery, Polyplexes delivered immobilization of 1.3 pglcm2. Transfected cells were visible 
from FBS-PS surfaces also had greater percentages of cells across the substrate (FIG. 24A), and transgene expression 
transfected compared to PS surfaces; however, transfection 20 measured at RLU15000 seeded. These 
efficiencies were low (<lo%, data not shown). results demonstrate the potential to apply substrate-mediated 
delivery to alternative substrates other than PS, including 
Cell-Complex Interaction biomaterials used in biomedical applications such as tissue 
The ability of cells to promote release of complexes from engineering, 
the substrate for subsequent internalization was examined by 
25 performing release studies with conditioned growth media. summary of ~~~~~l~ 5 
In conditioned media, the release of DNA complexes was Polyplexes immobilized to FBS-PS provided greater 
greater with FBS-PS surfaces with PS 21A)' transfection than polyplexes immobilized to PS, and equiva- 
After 8 days, 35% of polyplexes were released from PS 
surfaces and 47% were released from FBS-PS surfaces in lent or greater transfection than bolus delivery of complexes. 
conditioned media, These numbers are significantly greater 30 L i~o~ lexes ,  provide levels transgene 
than release studies in PBS (FIG, 17B). Lipoplexes exhib- On serum coated and uncoated surfaces. Inter- 
ited similar dependence on serum coating, with 23% and estingly, transfection on serum coated surfaces increases the 
15% released from FBS-PS and p s  substrates, respectively, number of transfected cells relative to uncoated surfaces. 
 hi^ quantity released in conditioned media is consistent Immobilized complexes are able to transfect primary cells, 
with amount released in PBS, with the primary difference 35 and result in lower cytotoxicity relative to bolus delivery. 
being that maximal release was reached sooner in condi- Finally, this delivery Inechanism can be adapted to bioma- 
tioned media. The differences in transfection observed terial surfaces, such as PLG, which is commonly used for 
between PS and FBS-PS were subsequently examined using such as tissue engineering. 
confocal microscopy to determine the relative distribution of 
40 
polyplexes and cells on the substrate. Conditions with rela- Example 6 
tively low (PS) and high (FBS-PS) transfection were com- 
pared to identify differences in the complex distribution, DNA Delivery from Hyaluronic Acid-Collagen 
(NIP 25, 2 pg incubated on the surface). Polyplexes immo- 
bilized to PS, which had low transfection were distributed 45 ~ ~ ~ ~ r i ~ l ~  and ~ ~ h ~ d ~  
across the surface, with a fraction of the complexes associ- 
Sodium hyaluronan (HA) was a gift from Genzyme 
ated with 22A)' For seeded Onto DNA Corporation (1330 kDa, Cambridge, Mass.). The crosslinker 
adsorbed FBS-PS substrates that yielded higher transfection, 
poly(ethy1ene glycol) diglycidyl ether (CH20CH- 
polyplexes were not distributed across the substrate, but 
were localized to the cells or their vicinity. Thus, polyplexes 
(CH2CH20)n-CHOCH2, PEGDG, ~ 2 0 0 )  was purchased 
50 from Polysciences (Warrington, Pa.). Adipic acid dihy- 
had a higher cellular association when delivered from 
serum-modified surfaces than compared to unmodified sur- drazide (AAD), N-(3-dimethylpropy1)-N-ethylcarbodiimide 
hydrochloride (EDC) and N-hydroxysulfosuccinimide 
faces. 
sodium salt (sulfo-NHS) were purchased from Sigma (St 
Primary Cell Transfection Louis, Mo.). Collagen was isolated from rat tails according 
The ability of substrate-mediated delivery to transfect 55 to the procedure described by Choe et al. (Choe M M, Spom 
primary cells was assessed using human dermal fibroblasts, P H, Swartz M A,, Am J Physiol Lung Cell Mol Physiol, 
a cell that has been difficult to transfect due to cytotoxicity. 2003;285(2):L427). Plasmid DNAencoding for luciferase or 
Polyplexes delivered as a bolus resulted in large amounts of green fluorescent protein was purified from bacteria culture 
cellular debris, poor cell morphology and reduced cellular using Qiagen (Santa Clara, Calif.) reagents and stored in 
viability (FIG. 23A). For substrate-mediated delivery, the 60 Tris-EDTA buffer solution (pH=7.4). Linear PEI, biotiny- 
fibroblasts had a morphology similar to that observed during lated linear PEI (PEI-Biotin), and arginine-glycine-aspar- 
typical cell culture (FIG. 23B). Transgene expression was tic acid modified linear PEI (RGD-PEI) were purchased 
greatest for fibroblasts cultured on FBS-PS, with both from PolyTransfection (7 mm m i n e  content, Strasbourg, 
immobilized polyplexes and lipoplexes (FIG. 23C, 23D). France). Neutravidin (NA) and biotin reagents for HA 
Polyplexes delivered from a FBS-PS surface yielded 10.7 65 modification were purchased from Pierce (Rockford, Ill.). 
fold greater luciferase expression when compared to PS, All other reagents were obtained from Fisher Scientific 
with bolus delivery producing luciferase activity similar to (Fairlawn, N.J.) unless otherwise noted. 
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Synthesis of Biotinylated-Hyaluronic Acid DNMCationic Polymer Release 
HA was biotinylated by first modifying its backbone with The percentage of DNMPEI complexes released from the 
adipic acid dihydrazide (AAD) and then reacting the pen- hydrogel was determined using 3 2 ~ - ~ ~ ~  complexes immo- 
dant hydrazide groups with sulfo-NHS-Lcbiotin (NHS-Bi- bilized to NA bound HA-collagen hydrogels. After washing 
otin) (Segura T, Anderson B C, Chung P H, Webber R E, 5 the hydrogels, PBS (pH 7.4), conditioned media (DMEM 
Shull K R, Shea L D. Crosslinked hyaluronic acid hydrogels: with 10% FBS from 2-day NIHl3T3 culture) or hyalu- 
a strategy to functionalize and pattern. Biomaterials 2004; in ronidase (HAase, 100 Ulml) was added (200 ml) and the 
press). Briefly, EDC (0.5 equivalents) and sulfo-NHS (0.5 surfaces were incubated at 37' C. in a humid chamber. The 
equivalents) were added as solids to the HA solution (10 HAase concentration was chosen to obtain significant hydro- 
mglml), followed by AAD (30 equivalents) addition. The lo  gel degradation during the 8-day study. At predetermined 
reaction proceeded at room temperature for 16 h with time-points, solution (100 ml) was removed with replace- 
mixing. HA-AAD was precipitated and washed in cold ment, to minimize hydrogel disruption. The activity of the 
ethanol. The precipitate was stored at 4' C. until use. Biotin collected sample was measured in a scintillation counter, 
was introduced to HA-AAD (HA-Biotin) using NHS-Biotin. with the hydrogel also measured at the final time point. The 
NHS-Biotin (100 mg) was added as a solid to HA-AAD (300 percentage of DNA released was calculated by dividing the 
mg, 3 mglml in PBS, pH 7.4). The reaction proceeded for 16 l 5  amount released at a given time-point by the initial amount 
h at room temperature with stirring, and the product was immobilized. 
purified by ethanol precipitation. 
Cell Culture and Transfection 
Hyaluronic AcidCollagen Hydrogel Synthesis All transfection studies were performed using an NIP ratio 
HA-collagen hydrogels were formed using the reaction of 20 of 5 with complexes formed in either 150 mm NaCl or water. 
the alcohols of biotinylated HA with the PEGDG crosslinker NIHl3T3 cells, a fibroblast cell line, were used to simulate 
as previously described (Segura T, Anderson B C, Chung P in vivo delivery to fibroblasts (Bonadio J, Smiley E, Patil P, 
H, Webber R E, Shull K R, Shea L D., Biomaterials 2004; Goldstein S., Nat Med 1999;5 (7):753-9). Cells were plated 
in press). The hydrogels were formed with a final collagen (10,000 cellslwell) on the modified hydrogel substrates and 
concentration of 0.19 mglml. A topographical pattern was 25 cultured for 2 days at 37' C. and 5% CO, in DMEM 
introduced into the hydrogel using a pattern transfer method. (Invitrogen, Gaithersburg, Md.) supplemented with 10% 
NA was bound by hydration of the hydrogel in a 1 mm NA heat-inactivated FBS and 1% penicillidstreptomycin. The 
solution in PBS for 1 h, followed by PBS wash. ability of complexes released from the hydrogel to promote 
gene transfer was examined by placing the hydrogels in 
Size and Zeta Potential Measurements culture above NIHl3T3 cells (15,000 cellslwell) in 48-well 
Size and zeta potential of DNMPEI complexes were 30 plates. The DNA-modified hydrogels were not in direct 
measured using a Zetasizer Nan0 Z S instrument (Malvern, contact with the adhered cells. Additionally, cellular inter- 
Worcestershire, UK). For com~lexation, DNA (50 ml, 40 actions with the immobilized DNA complex was investi- 
mglml) was mixed with PEI at nitrogen to phosphate (NIP) gated through incorporation of an RGD peptide into the 
ratios ranging from 2.5 to 20. Complexes were formed in complex, which increase cellular interactions with the com- 
either water or 150 mm NaCl in a volume of 100 ml. After 35 through integrin receptor binding to RGD K, 
a 10-min incubation, complexes were diluted 10 times with Merdan T, Hegener 0 ,  Haberlein H, Kissel T., J Gene Med 
either water or 150 mm NaCl. To examine complex aggre- 2003;5(7):588-99). Complexes were formed with a constant 
gation, complexes were formed in water and diluted 10 amount of PEIBiotin (25%) and varying amounts of RGD- 
times with 150 mm NaCl, with size monitored over time. pEI (10-75%). The extent of transgene exllression elicited 
DNMPEI Complex Immobilization 
DNA complexes were immobilized to HA-collagen 
hydrogels by incubation of complexes with the NA bound 
HA-collagen hydrogel. DNA (50 ml of 40 mglml in 150 mm 
NaCl or water) was complexed with PEI (50 ml of 150 mm 
NaCl or water) at a NIP ratio of 5. Mixing biotinylated and 
non-biotinylated PEI prior to mixing with DNA varied the 
degree of biotinylation for the complex. The complexes 
were incubated for 10 min, transferred to NA bound HA- 
collagen surfaces, and incubated for 2 h at room tempera- 
ture. The unbound complexes were removed and the sur- 
faces were washed extensively with PBS buffer. Surface 
binding of the DNMPEI complexes was examined using 
labeled DNA. Plasmid DNA was radiolabeled with a-32P 
dATP using a nick translation kit (Amersham Pharmacia 
Biotech, Piscataway, N.Y.) (Segura T, Volk M J, Shea L D., 
J Control Release 2003;93(1):69-84). 32P-DNMPEI com- 
plexes were formed and immobilized to the surface using the 
described procedures. Following immobilization, the hydro- 
gels were placed in scintillation cocktail (5 ml, ScintiVerse 
11) and radioactivity measured with a scintillation counter. 
The measured activity was correlated to DNA mass with a 
standard curve. For visualization of immobilized DNMPEI 
complexes, DNA was labeled with tetramethyl rhodamine 
using a commercially available kit (label IT TMRhodamine, 
Mirus, Madison, Wis.). Images of the complexes on HA 
after extensive washing with PBS buffer were captured 
using a fluorescence microscope (Leica, Bannockburn, Ill.) 
equipped with a digital camera. 
u 
by the DNA-modified surfaces was examined using the 
reporter genes luciferase. For measurements of luciferase 
activity, the cells were lysed and assayed for luciferase 
enzymatic activity (Promega, Madison, Wis.). The lumi- 
nometer was set for a 3-s delay and an integration of the 
signal for 10 s. Transgene expression of luciferase is 
reported as RLU per number of cells seeded. The number 
and distribution of transfected cells was determined with 
green fluorescent protein (GFP) expression and fluorescence 
microscopy. Complexes with 25% biotinylated PEI were 
immobilized onto the hydrogel surface. NIHl3T3 cells (7000 
cellslwell) were plated on topographically patterned-DNA 
modified hydrogels and cultured for 48 h. The cytoskeleton 
and nucleus of cells were stained with rhodamine phalloidin 
(1 Ul200 ml) and Hoechst (1 mglml) stains, respectively 
(Molecular Probes, Eugene, Oreg.). Five pictures per trip- 
licate were taken with a fluorescence microscope and ana- 
lyzed. The percentage of transfected cells was calculated as 
the ratio of GFP-positive cells to total number of nuclei 
(Hoechst). 
Results 
DNMPEI Complex Characterization 
The dependence of the z-average diameter (dz) for the 
DNA complexes was determined at two salt concentrations 
(150 mm NaCl, pure water) and varying NIP ratio. dz for 
PEIlDNAcomplexes was an order of magnitude larger in the 
presence of salt (FIG. 25A). At an NIP ratio of 5, dz was 
equal to 139.4+1-1.3 nm in water, and 1221.7+1-152.3 nm 
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in 150 mm NaCl. Additionally, complex diameter decreased 48.7+1-5.4% of adhered cells, whereas large diameter com- 
with increasing NIP ratio in both 150 mm NaCl and water plexes resulted in a transfection percentage of 22.3+1-5.8% 
(FIG. 25A). For 150 mm NaCl, dz ranged from 848.9+1- (FIG. 30B). 
63.6 ~1 (NIP 20) to 1778+1-227.7 ~1 (NIP 2.5). In water, Mechanism of DNA Internalization 
dz ranged from 125.6+1-2.3 nm 20) 173.9+1-2.2 nm The mechanism of DNAinternalization from the substrate 
(NIP 2.5). The zeta potential of complexes in 150 mm NaCl was examined by examining release from the substrate, the 
also increased with increasing NIP ratio with values ranging ability of released complexes to transfect cells, and the role 
from -11.0+1-2.3 mV to 24.4+1-0.6 mV for complexes of speci.c cellular interactions with the complexes. Incuba- 
formed with 2.5 and 20 NIP ratios, respectively (FIG. 25B). tion of hydrogels with immobilized DNA complexes in PBS 
10 
Complexes formed in the absence of salt aggregated upon (FIG. 31A), conditioned media (FIG. 31B), and hyalu- 
addition of salt, ~h~ dz was monitored before and after salt ronidase (FIG. 31C) indicated that complexes were released 
addition for a total tirne of76 min (FIG, 26). ~h~ complexes from the substrate, with conditioned media producing the 
increased in size upon salt addition, with dz increasing from maximal release. After 24-h incubation, conditioned media 
139,7+/-1,3 nm to 342,7+1-12,8 nm immediately after salt l5 induced release for approximately 50% of the immobilized 
addition for an NIP ratio of 5, PEI/DNA complex dz DNA, which is substantially greater than release in either 
increased further with increased incubation time, reaching PBS or hyaluronidase. Release of biotinylated or non- 
biotinylated complexes was significantly different (pe0.05) 
758.7+1-53.8 nm after 76 min of incubation. This trend of primarily at the time point, with the greatest difference 
increasing complex diameter with salt and time was 
observed for all NIP ratios (FIG. 26). 
observed for release in conditioned media. 
20 
After 8-day incubation in PBS, conditioned media, and 
Surface Immobilization hyaluronidase, the percentage of non-biotinylated com- 
DNA immobilization to the hydrogel was independent of plexes released was 51.6+1-1.5, 58.7+1-6.4, and 78.6+1- 
salt content during complex formation and the extent of 8.8%, respectively. For biotinylated complexes, the percent- 
biotinylation, Quantities immobilized to the hydrogels 25 age was 43.4+1-5.3, 83.3+1-3.1, and 
ranged from 0,411+1-0,042 to 0,484+1-0,014 mg DNA, 94.7+1-0.5% for substrates incubated in PBS, conditioned 
with no significant difference between conditions (p>0.05; media, and hyaluronidase, 
FIG, 27A). Immobilization preserved the complex size that Incubation of DNA-immobi1ized hydrogels with NIH1 
was observed in solution, Complexes formed in salt and 3T3 On tissue polystyrene was per- 
deposited on the surface were visualized as discrete particles 3o fo'med to assess the role of cellular adhesion to the substrate 
on the surface (FIG, 2 7 ~ ) .  conversely, complexes formed in 1" gene transfer. Complexes released from the hydrogel did 
water resulted in more diffuse fluorescence without large not efficiently transfect cells that were not cultured on the 
aggregates, consistent with small particle deposition (FIG, substrate 32). Luciferase was 01 RLU=lO; 
27C). 000 cells by incubation of hydrogels with cells cultured on 
polystyrene, which is significantly less than expression 
35 
Cellular Transfection levels observed when cells were cultured on the hydrogel 
Complexes with plasmid encoding for GFP were immo- (>105RLU=10; OoO 
bilized to the topographically patterned hydrogel substrates Inc0qoration RGD peptides the DNA 
in order to visualize the distribution of transfected cells, which was hypothesized to increase cellular interactions 
NIH/3T3 cells plated and cultured on HA-collagen hydro- 40 with the RGD binding integrin recep- 
gels oriented consistently with the pattern on the hydrogel tors, resulted in lower transgene expression than unmodified 
surface. Visualization of the cytoskeleton (phalloidin) by complexes (FIG. 33). For all the conditions tested, the 
fluorescence microscopy demonstrated that the cells were presence RGD in the decreased transgene 
aligned with the pattern. Additionally, NIH/3T3 cells cul- expression relative to the absence of RGD ~ e ~ t i d e s .  1n the 
bred on the DNA-modified hydrogel substrates were found 45 absence RGD peptides, transgene was .24+1- 
to express the transgene in this oriented conformation (FIG. 0.08x105 RLU1lO,OOO The Presence RGD at levels 
28). of 10% and 25% resulted in mean expression levels of 
approximately 7 x 1 0 ~  RLUl10,OOO cells. Further increases in 
The role of complex size, which was regulated by salt 
content during complex formation, in gene transfer for PEI-RGD content to 50% and 75% reduced mean transgene 
expression to less than 2x104 RLUl10,OOO cells. 
substrate-mediated delivery was examined by measuring the 50 
extent of transgene expression and percentage of transfected 
cells. Complex size significantly affected transgene expres- 
sion, with large diameter complexes (formed in NaCl) 
resulting in increased luciferase expression relative to small 
diameter complexes (formed in water, FIG. 29). Maximal 
transgene expr5ssion levels were 1.62+1-0.67x105 and 
4.28+1-0.62~10 (RLUl10,OOO cells) for the large and small- 
diameter complexes, respectively (FIG. 29). Furthermore, 
complexes formed with biotinylated PEI resulted in statis- 
tically higher luciferase expression than non-biotinylated 
complexes (pe0.05; FIG. 29). No difference in expression 
Summary of Example 6 
Complexes formed in the presence of salt had a z-average 
diameter equal to 1221.7+1-152.3 nm, while formation in 
water produced complexes with z-average diameter of 
55 139.4+1-1.3 nm. Complexes immobilized to the hydrogel 
had sizes consistent with their size in solution, and did not 
aggregate. The quantity of complexes immobilized was 
independent of the complex size and the extent of biotiny- 
lation. DNA release from the hydrogel substrate was 
60 enhanced by incubation with conditioned media, with 
release at 48 h equal to 49.7+1-8.1% and 49.2+1-2.9% for 
was observed for complexes formed with different extents of non-biotinylated and biotinylated complexes, respectively. 
biotinylation (p>0.05). The percentage of transfected cells Transfection studies showed that transgene expressionmedi- 
by the different complexes was subsequently examined to ated by large complexes was 3- to 7-fold greater than with 
determine if increased luciferase production correlated with 65 small complexes. However, the number of cells expressing 
a higher percentage of transfected cells (FIG. 30A). How- the transgene was increased with small complexes (48.7%), 
ever, small diameter complexes resulted in transfection of relative to large complexes (22.3%). Finally, the hydrogel 
US 7,029,697 B2 
45 46 
was patterned topographically, which guided and oriented 
cell attachment to the substrate and resulted in spatial TABLE I 
patterns of transfected cells on the hydrogel. 
Contact Angle Measurements for Substrates (water) 
In summary, efficient and controlled DNA delivery from 
biomaterial substrates has the potential to enhance the Sufiace Contact Angle (deg) 
applicability of gene delivery to tissue engineering. We have Tissue Culture Polystyrene (PS) 47.75 +/- 6.64 
fabricated hydrogels with the ability to transfect adherent FBS Modified Tissue Culture polystyrene (FBS-PS) 12.67 +I- 3.13 
cells using immobilized DNA complexes, which can be 
manipulated to alter the number of transfected cells and the l o  
extent of transgene expression. Additionally, these hydro- What is is: 
gels can be patterned to regulate cell attachment and orient 1. A method for increasing transgene expression, corn- 
cell growth, which results in spatial patterns of transfected prising making a nucleic acid system, 
said system comprising forming nucleic acid polylinker 
cells. 
15 complexes capable of being delivered to cells cultured on a 
support substrate, wherein said complexes are formed prior 
Example 7 to being covalently or non-covalently immobilized to the 
surface of a support substrate, and wherein said method 
Patterned Transfection on Gold Substrates comprises: 
20 a) contacting a nucleic acid with a polylinker to form a 
Self-assembled monolayers (SAMs) of alkanethiols on nucleic acid-polylinker complex, said complex being 
gold were used to spatially pattern surfaces with chemically formed prior to attachment to a support substrate; and 
active groups to regulate the location of DNA delivery from b, the acid-~ol~linker to a 
support substrate; and 
the surface (FIGS. 34 and 35). A self-assembled monolayer 
25 wherein said cells are added to the support substrate after 
is a single layer of molecules on a substrate in which the immobilization of the nucleic acid-polylinker complex to the 
molecules exhibit a high degree of orientation, molecular support substrate, 
and packing. The monolayer forms 2. The method of claim 1, further comprising modification 
upon exposure of the substrate to an ethanol solution con- of the substrate with serum prior to addition of the 
taining the molecules. Alkanethiols form well-packed and 30 nucleic acid-polylinker complex, and wherein said modifi- 
stable monolayers on gold through a thiolate linkage. A cation allows for an increase in transgene expression. 
poly(dimethylsiloxane) (PDMS) stamp was used to imprint 3. The method of claim 1, wherein the extent of transgene 
gold surfaces with specific patterns of  SAM^ of mercapto- expression is dependent upon substrate modification and 
1 -undecanol (MUOH) or 1 1 -mercaptoundecanoic acid 
(WA) according to the method of ulman, A, (1996). 35 4. The method of claim 1, wherein said nucleic acid 
Formation and Structure of Self-Assembled Monolayers, P ~ ~ Y ~ ~ ~ ~ ~  are P ~ ~ Y P ~ ~ ~ ~ ~  Or lip0plexes. 
Chem Rev 96, 1533-1554. The stamped surface was then 5' The method of wherein said substrate 
is polystyrene, gold, hyaluronic acid collagen hydrogels or 
immersed into a solution of 2 mM 1-decanethiol (DTlO), polylactide-co-glycolide (PLG), 
creating regions with different properties allowing for physi- 40 6, The method of claim 2, wherein said substrate modi- 
cally distinct regions of complexes. Complexes were formed fication is made by treatment with serum, 
with a plasmid encoding for eGFPILuciferase, complexed 7, l-he method ofclaim 1, wherein delivery of the nucleic 
with Lipofectamine at a 1:2.5 DNA: Lipofectamine ratio. acid-polylinker complexes to cells occurs from a polysty- 
The complexes were then deposited on the surface for 2 rene surface treated with serum, and wherein said delivery 
hours. The surfaces were then washed and NIHl3T3 fibro- 45 results in similar or greater percentage of transfected cells 
blasts were seeded. Luciferase expression was assayed 24 relative to bolus delivery. 
hours later. Alternatively, cells were seeded onto the 8. The method of claim 1, said method further comprising 
alkanethiol modified gold surface and DNA complexes were release of the nucleic acid from the nucleic acid-polylinker 
then added as a bolus. 50 complexes, wherein said release is maximized when the 
support substrate is treated with serum. 
As shown in FIG. 35, complexes adsorbed on the hydro- 
9. A method for increasing transgene expression, com- 
philic, charged MUA transfected with greater efficiency than 
prising making a controlled nucleic acid delivery system, 
On MUOH, DT1O, Or the umnOdified said system comprising forming nucleic acid polyli&er 
gold surface. Very little was transfected when DNA 55 complexes capable of being delivered to cells cultured on a 
was delivered as a bolus. support substrate, wherein said complexes are covalently or 
The present invention is not to be limited in terms of the non-covalently immobilized to the surface of a support 
particular embodiments described in this application, which substrate, and wherein said method comprises: 
are intended as single illustrations of individual aspects of a) contacting a nucleic acid with a polylinker to form a 
the invention. Functionally equivalent methods and appara- 60 nucleic acid-polylinker complex; 
tus within the scope of the invention, in addition to those b) immobilizing the nucleic acid-polylinker complex to a 
enumerated herein, will be apparent to those skilled in the art support substrate; and 
from the foregoing description and accompanying drawings. c) adding cells to the support substrate after immobiliza- 
Such modifications and variations are intended to fall within tion of the nucleic acid-polylinker complex to the 
the scope of the appended claims. The contents of each 65 support substrate, 
reference, patent and patent application cited in this appli- wherein the release of nucleic acid from the nucleic 
cation is hereby incorporated by reference in its entirety. acid-polylinker complexes is further enhanced when 
the support substrate containing the complexes is 17. The method of either one of claim 1 or 11, wherein 
treated with serum or is incubated in conditioned said nucleic acid polylinker complexes are immobilized to 
medium. the support substrate using biotin and avidin, or an avidin 
10. The method of claim 2, wherein the delivery of the derivative, or by non-specific adsorption. 
nucleic acid-polylinker complexes to cells from a serum- 5 18. The method of claim 17, wherein said avidin deriva- 
modified support substrate results in higher cellular asso- tive is streptavidin or neutravidin. 
ciation of the nucleic acid-polylinker complexes with the 19. The method of any one of claim 11-15, wherein the 
support substrate. method further comprises controlling the size of the nucleic 
11. A method for increasing transgene expression, com- acid polylinker complex by regulating the salt content 
prising the steps of l o  during complex formation. 
a) making a controlled nucleic acid delivery system by 20. The method of claim 19, wherein controlling the size 
contacting a nucleic acid with a polylinker to form a of said complex formation is accomplished by the presence 
nucleic acid-polylinker complex, wherein said complex or absence of salt during the formation of the complexes, 
is formed prior to addition to a support substrate; wherein the forming of large diameter complexes in the 
b) immobilizing the nucleic acid-polylinker complex to a 1s presence of salt results in increased transgene expression, 
support substrate; wherein said immobilizing is accom- and wherein the forming of small diameter complexes in the 
plished by covalent or non-covalent means, and absence of salt results in a greater percentage of cells being 
c) adding the cells into which transgene expression is transfected. 
desired to the support substrate after immobilization of 21. The method of claim 19, wherein the salt is sodium 
the nucleic acid-polylinker complex to the support 20 chloride. 
substrate. 22. A method for increasing transgene expression, com- 
12. The method of claim 11, wherein said support sub- prising the steps of 
strate comprises a biodegradable or non-biodegradable a) making a controlled nucleic acid delivery system by 
material. contacting a nucleic acid with a polylinker to form a 
13. The method of either one of claim 1 or 11, wherein 25 nucleic acid-polylinker complex; 
said complexes are formed prior to attachment to the solid b) immobilizing the nucleic acid-polylinker complex to a 
support substrate. support substrate; wherein said immobilizing is accom- 
14. The method of claim 12, wherein said biodegradable plished by covalent or non-covalent means, and 
material is a hydrogel and said non-biodegradable material c) adding the cells into which transgene expression is 
is polystyrene or gold. 30 desired to the support substrate after immobilization of 
15. The method of claim 12, wherein said hydrogel the nucleic acid-polylinker complex to the support 
comprises a mixture of hyaluronic acid and collagen. substrate, 
16. A method for increasing transgene expression, wherein said method further comprises release of the nucleic 
wherein said method promotes transfection of primary cells, acid from the substrate, wherein the release is optimized by 
comprising the steps of  35 using conditioned medium. 
a) making a controlled nucleic acid delivery system by 23. The method of claim 11, wherein said method further 
contacting a nucleic acid with a polylinker to form a comprises biotinylation of said complex to enhance release 
nucleic acid-polylinker complex; of said complex from said substrate. 
b) immobilizing the nucleic acid-polylinker complex to a 24. The method of either of claim 1 or 11, wherein the 
support substrate; wherein said immobilizing is accom- 40 nucleic acid is DNA, RNA or an oligonucleotide. 
plished by covalent or non-covalent means, and 25. The method of claim 24, wherein said oligonucleotide 
c) adding the cells into which transgene expression is is an antisense oligonucleotide or a catalytic RNAcapable of 
desired to the support substrate after immobilization of interfering with the expression of a gene. 
the nucleic acid-polylinker complex to the support 26. The controlled nucleic acid delivery system of either 
substrate, wherein the biodegradable material is a 45 of claim 1 or 11, wherein the polylinker is a cationic 
hydrogel and the non-biodegradable material is poly- polymer, cationic lipid, cationic protein, or cationic peptide. 
styrene or gold, and wherein the hvdrogel comprises a 
mixture of hyaluronic acid and collagen. * * * * *  
